七戸 秀夫 (シチノヘ ヒデオ)

北海道大学病院 医療・ヘルスサイエンス研究開発機構教授

研究者基本情報

■ 学位
  • 医学博士, 北海道大学
■ URL
researchmap URL■ ID 各種
J-Global ID■ 研究キーワード・分野
研究キーワード
  • Bone marrow stromal cell
  • Spinal cord injury
  • Differentiation
  • Neuroprotection
  • Cerebral stroke
  • Migration
  • 脊髄損傷
  • 骨髄間質細胞
  • 脳梗塞
  • サイトカイン
  • 中枢神経再生医療
  • PET
  • バイオマテリアル
  • 光イメージング
  • 幹細胞移植
  • Regenerative medicine
  • Diffuse axonal injury
  • 再生医療
  • Cerebral infarction
  • Functional restoration
  • Regeneration
  • 機能回復
  • transplantation
  • 脳挫傷
  • 脳損傷
  • biomaterial
  • 神経再生
  • 抗血管新生因子
研究分野
  • 人文・社会, 哲学、倫理学, 生命倫理、研究倫理、臨床研究、脳神経倫理学
  • ライフサイエンス, 脳神経外科学, 脳卒中、再生医療
■ 担当教育組織

経歴

■ 経歴
経歴
  • 2021年04月 - 現在
    北海道大学大学院文学研究院, 応用倫理・応用哲学研究教育センター, 研究員
  • 2021年04月 - 現在
    北海道大学病院, 医療・ヘルスサイエンス研究開発機構 臨床研究監理センター, 准教授
  • 2020年07月 - 現在
    株式会社RAINBOW, 研究開発担当取締役
  • 2017年01月 - 2021年03月
    北海道大学病院, 臨床研究監理部長, 准教授
  • 2016年09月 - 2016年12月
    北海道大学病院, 臨床研究開発センター, 准教授
  • 2015年04月 - 2016年08月
    北海道大学大学院医学研究科, 脳神経外科, 特任助教
  • 2015年02月 - 2016年08月
    (独) 医薬品医療機器総合機構, 再生医療製品等審査部, 特任職員(非常勤)
  • 2010年08月 - 2015年03月
    北海道大学病院, 脳神経外科, 助教

研究活動情報

■ 論文
  • Serial brain FDG-PET and IMZ-SPECT following intracerebral MSC transplantation in patients with subacute ischemic stroke.
    Masahito Kawabori; Kenji Hirata; Hideo Shichinohe; Shiro Watanabe; Arisa Miura; Yoichi M Ito; Kohsuke Kudo; Satoshi Kuroda; Kiyohiro Houkin; Miki Fujimura
    Stem cell research & therapy, 2026年05月12日, [国際誌]
    英語, 研究論文(学術雑誌), Ischemic stroke is a leading cause of mortality and long-term neurological disability worldwide, and cell-based therapies represent a promising approach. Although clinical studies have reported favorable outcomes following cell transplantation, the effects on host neuronal integrity remain incompletely understood. This study investigated temporal and spatial changes in fluorodeoxyglucose positron emission tomography (FDG-PET) and 123I-iomazenil single-photon emission computed tomography (IMZ-SPECT) after intracerebral cell transplantation in patients with subacute ischemic stroke and examined their relationship with functional recovery. Seven adults with severe post-stroke disability underwent autologous mesenchymal stromal cell (HUNS001-01) transplantation 47-64 days after stroke onset. Brain FDG-PET and IMZ-SPECT were performed preoperatively and at 1, 3, and 12 months post-transplantation. Regions of interest were first manually set in the ipsilateral cortex where the 12-month postoperative-to-preoperative standard uptake value ratio seems increased, and followed by quantitative measurement. Five of seven patients demonstrated 5% or more increase of FDG-PET and/or IMZ-SPECT uptake in peri-infarct cortical regions, predominantly within the frontal or temporal cortex. Transplanted cells localized either within metabolically enhanced regions or in anatomically remote areas. FDG-PET and IMZ-SPECT changes were strongly interacted in each other and were associated with functional improvement. Overall, improvement of glucose metabolism and synaptic density/viability were observed in patient with subacute ischemic stroke, which may have been attributable to cell transplantation.Trial registration: UMIN000026130.
  • Phase I/II trial of intracerebral transplantation of autologous bone marrow stem cells combined with recombinant peptide scaffold for patients with chronic intracerebral haemorrhage: a study protocol.
    Masahito Kawabori; Hideo Shichinohe; Kaoru Kahata; Arisa Miura; Kenichiro Maeda; Yoichi M Ito; Masahiko Mukaino; Ryo Kogawa; Kentaro Nakamura; Shuho Gotoh; Kota Kurisu; Miki Fujimura
    BMJ open, 14, 12, e083959, 2024年12月02日, [国際誌]
    英語, 研究論文(学術雑誌), INTRODUCTION: Intracerebral haemorrhage (ICH) stands as a leading global cause of death and disability, posing a significant challenge with limited treatment options, especially for chronic patients. Recent advances in stem cell therapies have opened new avenues for therapeutic potential. Our previous preclinical research has demonstrated that intracerebral transplantation of bone marrow stromal cells (BMSCs) combined with a recombinant human collagen type I scaffold enables higher cell survival and engraftment and holds promising potential. In this article, we present the protocol for a novel clinical trial, named 'Research on Advanced Intervention using Novel Bone MarrOW stem cells for chronic intracerebral haemorrhage' (RAINBOW-Hx). METHODS AND ANALYSIS: RAINBOW-Hx is a phase I/II, open-label, uncontrolled study with the primary objective of assessing the safety and efficacy of intracerebral transplantation of autologous BMSCs combined with the scaffold (HUFF-01) in patients with chronic ICH. Eight patients, experiencing moderate to severe neurological deficits for 12 months or longer, will be enrolled. The haemorrhage location will be limited to the basal ganglia and thalamus. Approximately 50 mL of bone marrow will be extracted from the iliac bone of each patient, and BMSCs will be cultured using autologous platelet lysate. 3 days before transplantation, BMSCs will be combined with the scaffold to generate HUFF-01. Each patient will receive a 50 000 HUFF-01 dose, containing approximately 50 million BMSCs, through stereotactic transplantation into the haemorrhagic cavity. Neurological assessments, MRI, 18F-fluorodeoxyglucose positron emission tomography and 123I-Iomazenil single-photon emission CT will be performed for 1 year after administration. ETHICS AND DISSEMINATION: The trial protocols were reviewed and approved by the Institutional Review Board of the Hokkaido University Hospital (R5-11), and this study is conducted according to Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. The results of this trial will be submitted for publication in a peer-reviewed scientific journal. TRIAL REGISTRATION NUMBER: jRCT2013230053, Japan Registry of Clinical Trials.
  • Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke.
    Masahito Kawabori; Satoshi Kuroda; Hideo Shichinohe; Kaoru Kahata; Souichi Shiratori; Satoshi Ikeda; Taisuke Harada; Kenji Hirata; Khin Khin Tha; Masato Aragaki; Shunsuke Terasaka; Yoichi M Ito; Naoki Nishimoto; Shunsuke Ohnishi; Ichiro Yabe; Kohsuke Kudo; Kiyohiro Houkin; Miki Fujimura
    Med (New York, N.Y.), 2024年03月18日, [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Ischemic stroke is one of the leading causes of death and neurological disability worldwide, and stem cell therapy is highly expected to reverse the sequelae. This phase 1/2, first-in-human study evaluated the safety, feasibility, and monitoring of an intracerebral-transplanted magnetic resonance imaging (MRI)-trackable autologous bone marrow stromal cell (HUNS001-01) for patients with subacute ischemic stroke. METHODS: The study included adults with severe disability due to ischemic stroke. HUNS001-01 cultured with human platelet lysates and labeled with superparamagnetic iron oxide was stereotactically transplanted into the peri-infarct area 47-64 days after ischemic stroke onset (dose: 2 or 5 × 107 cells). Neurological and radiographic evaluations were performed throughout 1 year after cell transplantation. The trial was registered at UMIN Clinical Trial Registry (number UMIN000026130). FINDINGS: All seven patients who met the inclusion criteria successfully achieved cell expansion, underwent intracerebral transplantation, and completed 1 year of follow-up. No product-related adverse events were observed. The median National Institutes of Health Stroke Scale and modified Rankin scale scores before transplantation were 13 and 4, which showed improvements of 1-8 and 0-2, respectively. Cell tracking proved that the engrafted cells migrated toward the infarction border area 1-6 months after transplantation, and the quantitative susceptibility mapping revealed that cell signals at the migrated area constantly increased throughout the follow-up period up to 34% of that of the initial transplanted site. CONCLUSIONS: Intracerebral transplantation of HUNS001-01 was safe and well tolerated. Cell tracking shed light on the therapeutic mechanisms of intracerebral transplantation. FUNDING: This work was supported by the Japan Agency for Medical Research and Development (AMED; JP17bk0104045 and JP20bk0104011).
  • Intracerebral Transplantation of Mesenchymal Stromal Cell Compounded with Recombinant Peptide Scaffold against Chronic Intracerebral Hemorrhage Model
    Soichiro Takamiya; Masahito Kawabori; Tsukasa Kitahashi; Kentaro Nakamura; Yuki Mizuno; Hironobu Yasui; Yuji Kuge; Aki Tanimori; Yasuyuki Takamatsu; Kohei Yuyama; Hideo Shichinohe; Miki Fujimura
    Stem Cells International, 2022, 1, 10, Hindawi Limited, 2022年07月31日
    研究論文(学術雑誌), Background. Due to the lack of effective therapies, stem cell transplantation is an anticipated treatment for chronic intracerebral hemorrhage (ICH), and higher cell survival and engraftment are considered to be the key for recovery. Mesenchymal stromal cells (MSCs) compounded with recombinant human collagen type I scaffolds (CellSaics) have a higher potential for cell survival and engraftment compared with solo-MSCs, and we investigated the validity of intracerebral transplantation of CellSaic in a chronic ICH model. Methods. Rat CellSaics (rCellSaics) were produced by rat bone marrow-derived MSC (rBMSCs). The secretion potential of neurotrophic factors and the cell proliferation rate were compared under oxygen-glucose deprivation (OGD) conditions. rCellSaics, rBMSCs, or saline were transplanted into the hollow cavity of a rat chronic ICH model. Functional and histological analyses were evaluated, and single-photon emission computed tomography for benzodiazepine receptors was performed to monitor sequential changes in neuronal integrity. Furthermore, human CellSaics (hCellSaics) were transplanted into a chronic ICH model in immunodeficient rats. Antibodies neutralizing brain-derived neurotrophic factor (BDNF) were used to elucidate its mode of action. Results. rCellSaics demonstrated a higher secretion potential of trophic factors and showed better cell proliferation in the OGD condition. Animals receiving rCellSaics displayed better neurological recovery, higher intracerebral BDNF, and better cell engraftment; they also showed a tendency for less brain atrophy and higher benzodiazepine receptor preservation. hCellSaics also promoted significant functional recovery, which was reversed by BDNF neutralization. Conclusion. Intracerebral transplantation of CellSaics enabled neurological recovery in a chronic ICH model and may be a good option for clinical application.
  • Intracerebral Transplantation of Autologous Bone Marrow Stem Cell (BMSC) for Subacute Ischemic Stroke, Phase 1 Clinical Trial (RAINBOW Trial)
    Masahito Kawabori; Hideo Shichinohe; Satoshi Kuroda; Kiyohiro Houkin
    STROKE, 52, 2021年03月, [査読有り]
    英語
  • Corrigendum to "Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease".
    Masahito Kawabori; Aki Tanimori; Shinri Kitta; Hideo Shichinohe; Kiyohiro Houkin
    Stem cells international, 2021, 9796010, 9796010, 2021年, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • 脳梗塞に対する新規治療の開発-血栓回収療法時代のアンメットメディカルニーズと医薬品開発戦略- 主幹動脈閉塞脳梗塞患者に対する幹細胞脳内移植治験(RAINBOW研究)
    川堀 真人; 七戸 秀夫; 黒田 敏; 宝金 清博
    脳循環代謝, 32, 1, 52, 52, (一社)日本脳循環代謝学会, 2020年11月
    日本語
  • 脳梗塞急性期患者への自家BMSC脳内投与による再生治療(Phase 1)とPhase 2に向けた取り組み
    川堀 真人; 七戸 秀夫; 黒田 敏; 宝金 清博
    脳循環代謝, 32, 1, 60, 60, (一社)日本脳循環代謝学会, 2020年11月
    日本語
  • 脳神経細胞治療・遺伝子治療の実践 脳出血慢性期モデルに対する骨髄幹細胞+足場材製剤(CellSaic)の有効性
    高宮 宗一朗; 川堀 真人; 七戸 秀夫; 中村 健太郎; 北橋 宗; 岩澤 玲子; 古川 友子; 宝金 清博
    脳循環代謝, 32, 1, 68, 68, (一社)日本脳循環代謝学会, 2020年11月
    日本語
  • Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke.
    Masahito Kawabori; Hideo Shichinohe; Satoshi Kuroda; Kiyohiro Houkin
    International journal of molecular sciences, 21, 19, 2020年10月06日, [国際誌]
    英語, 研究論文(学術雑誌), Despite recent developments in innovative treatment strategies, stroke remains one of the leading causes of death and disability worldwide. Stem cell therapy is currently attracting much attention due to its potential for exerting significant therapeutic effects on stroke patients. Various types of cells, including bone marrow mononuclear cells, bone marrow/adipose-derived stem/stromal cells, umbilical cord blood cells, neural stem cells, and olfactory ensheathing cells have enhanced neurological outcomes in animal stroke models. These stem cells have also been tested via clinical trials involving stroke patients. In this article, the authors review potential molecular mechanisms underlying neural recovery associated with stem cell treatment, as well as recent advances in stem cell therapy, with particular reference to clinical trials and future prospects for such therapy in treating stroke.
  • Responses of immune organs following cerebral ischemic stroke.
    Chengbo Tan; Zifeng Wang; Miao Zheng; Songji Zhao; Hideo Shichinohe; Kiyohiro Houkin
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 88, 3, 228, 237, 2020年08月31日, [国内誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Stroke is a leading cause of death and disability worldwide. Recently, brain secondary damage has been hypothesized to be a key aggravating element in an ischemic cascade. However, the interaction between cerebral infarction and immune organs has yet to be fully understood. In this study, we investigated the changes in the rat brain, spleen, thymus, mesenteric lymph node, and liver at 3, 7, and 13 days after transient middle cerebral artery occlusion (tMCAO) by immunohistochemistry. MATERIAL AND METHODS: Rat models of stroke were made by tMCAO. Functional assessment was performed 3 h, and 1, 3, 5, 7, 9, 11, and 13 days after MCAO. Rat organs were harvested for 2,3,5-triphenyltetrazolium chloride staining and Immunohistochemistry. RESULTS: The CD8α+ T cells was found to decrease in the spleen, thymus, mesenteric lymph node, and liver, whereas it increased in the brain. Those of Iba1+ and CD68+ macrophages were decreased in the spleen, thymus, and mesenteric lymph node, whereas they were elevated in the brain and liver. Ki67+ cells showed the same characteristics as macrophages, and increased numbers of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive apoptotic cells were found in the spleen, mesenteric lymph node, liver, and brain. CONCLUSIONS: The present results demonstrated that stroke is a systemic disease, which not only affects the brain, but also induces responses of immune organs. On the basis of these results, a systemic treatment might be a good strategy for clinical stroke care.
  • 【放射線科医が知っておくべき 脳血管障害診療 update】脳血管障害に対する再生医療・細胞治療の現状と今後の展望
    川堀 真人; 七戸 秀夫; 黒田 敏; 寳金 清博
    臨床画像, 36, 4月増刊, 141, 150, (株)メジカルビュー社, 2020年04月, [査読有り]
    日本語
  • Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease.
    Masahito Kawabori; Aki Tanimori; Shinri Kitta; Hideo Shichinohe; Kiyohiro Houkin
    Stem cells international, 2020, 4085617, 4085617, 2020年, [査読有り], [国際誌]
    英語, Cell therapy for central nervous system (CNS) disorders is beginning to prove its safety and efficiency. Intraparenchymal transplantation can be an option for cell delivery; however, one concern regarding this method is that the transplantation cannula may cause additional brain injuries. These include vessel damage, which results in brain hemorrhage, and clogging of the cannula by brain debris and/or cell clusters, which requires replacement of the cannula or forced injection causing jet flow of the cell suspension. We compared cannulas for cell delivery used in clinical trials, the Pittsburg and Mizuho cannulas, to a newly designed one, MK01, to assess their usability. MK01 has a spherical-shaped tip with a fan-like open orifice on the side of the cannula, which prevents vessel damage, clogging of brain debris, and jet flow phenomenon. We compared the extent of rat cervical and abdominal arterial damage with the cannula, the amount of debris in the cannula, the force needed to cause jet flow, and cell viability. While the viability of cells passed through the cannulas was almost the same among cannulas (approximately 95%), the Pittsburg cannula caused cervical arterial injury and subsequent hemorrhage, as it required a significantly smaller force to penetrate the arterial wall. Moreover, the Pittsburg cannula, but not the Mizuho and MK01 cannulas, showed high frequency of brain debris in the needle tip (approximately 80%) after brain puncture. While jet flow of the injection liquid was observed even when using smaller forces in the Pittsburg and Mizuho cannulas, MK01 constantly showed low jet flow occurrence. Thus, MK01 seems to be safer than the previously reported cannulas, although further investigation is necessary to validate its safety for clinical use.
  • 脳梗塞亜急性期に対する自家骨髄間質細胞の脳内投与 第一相治験:RAINBOW研究
    川堀 真人; 七戸 秀夫; 黒田 敏; 寳金 清博
    脳循環代謝, 31, 1, 83, 83, (一社)日本脳循環代謝学会, 2019年11月, [査読有り]
    日本語
  • 【脳卒中-診断・治療の最新動向-】基礎研究 脳卒中患者に対する細胞移植・再生医療の現状と将来
    川堀 真人; 七戸 秀夫; 黒田 敏; 宝金 清博
    日本臨床, 77, 6, 945, 953, (株)日本臨床社, 2019年06月
    日本語
  • 脳梗塞亜急性期に対する自家骨髄幹細胞の直接投与(第一相治験:RAINBOW研究)
    川堀 真人; 七戸 秀夫; 黒田 敏; 寳金 清博
    神経治療学, 36, 6, S128, S128, 日本神経治療学会, 2019年
    日本語
  • [18F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia.
    Tan C; Zhao S; Higashikawa K; Wang Z; Kawabori M; Abumiya T; Nakayama N; Kazumata K; Ukon N; Yasui H; Tamaki N; Kuge Y; Shichinohe H; Houkin K
    EJNMMI research, 8, 1, 35, 35, 2018年05月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: The potential application of bone marrow stromal cell (BMSC) therapy in stroke has been anticipated due to its immunomodulatory effects. Recently, positron emission tomography (PET) with [18F]DPA-714, a translocator protein (TSPO) ligand, has become available for use as a neural inflammatory indicator. We aimed to evaluate the effects of BMSC administration after transient middle cerebral artery occlusion (MCAO) using [18F]DPA-714 PET. The BMSCs or vehicle were administered intravenously to rat MCAO models at 3 h after the insult. Neurological deficits, body weight, infarct volume, and histology were analyzed. [18F]DPA-714 PET was performed 3 and 10 days after MCAO. RESULTS: Rats had severe neurological deficits and body weight loss after MCAO. Cell administration ameliorated these effects as well as the infarct volume. Although weight loss occurred in the spleen and thymus, cell administration suppressed it. In both vehicle and BMSC groups, [18F]DPA-714 PET showed a high standardized uptake value (SUV) around the ischemic area 3 days after MCAO. Although SUV was increased further 10 days after MCAO in both groups, the increase was inhibited in the BMSC group, significantly. Histological analysis showed that an inflammatory reaction occurred in the lymphoid organs and brain after MCAO, which was suppressed in the BMSC group. CONCLUSIONS: The present results suggest that BMSC therapy could be effective in ischemic stroke due to modulation of systemic inflammatory responses. The [18F]DPA-714 PET/CT system can accurately demonstrate brain inflammation and evaluate the BMSC therapeutic effect in an imaging context. It has great potential for clinical application.
  • Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products.
    Houkin K; Shichinohe H; Abe K; Arato T; Dezawa M; Honmou O; Horie N; Katayama Y; Kudo K; Kuroda S; Matsuyama T; Miyai I; Nagata I; Niizuma K; Sakushima K; Sasaki M; Sato N; Sawanobori K; Suda S; Taguchi A; Tominaga T; Yamamoto H; Yamashita T; Yoshimine T; Working Group; for Guidelines on Development of Cell-Based; Products for the Treatment of Cerebral Infarction
    Stroke, 49, 4, e145, e152, 2018年04月, [査読有り]
  • Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke.
    Miyamoto M; Nakamura K; Shichinohe H; Yamauchi T; Ito M; Saito H; Kawabori M; Osanai T; Sasaki T; Houkin K; Kuroda S
    Stem cells international, 2018, 4829534, 4829534, 2018年, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Bone marrow stromal cell (BMSC) transplantation has the therapeutic potential for ischemic stroke. However, it is unclear which delivery routes would yield both safety and maximal therapeutic benefits. We assessed whether a novel recombinant peptide (RCP) sponge, that resembles human collagen, could act as a less invasive and beneficial scaffold in cell therapy for ischemic stroke. BMSCs from green fluorescent protein-transgenic rats were cultured and Sprague-Dawley rats were subjected to permanent middle cerebral artery occlusion (MCAo). A BMSC-RCP sponge construct was transplanted onto the ipsilateral intact neocortex 7 days after MCAo. A BMSC suspension or vehicle was transplanted into the ipsilateral striatum. Rat motor function was serially evaluated and histological analysis was performed 5 weeks after transplantation. The results showed that BMSCs could proliferate well in the RCP sponge and the BMSC-RCP sponge significantly promoted functional recovery, compared with the vehicle group. Histological analysis revealed that the RCP sponge provoked few inflammatory reactions in the host brain. Moreover, some BMSCs migrated to the peri-infarct area and differentiated into neurons in the BMSC-RCP sponge group. These findings suggest that the RCP sponge may be a promising candidate for animal protein-free scaffolds in cell therapy for ischemic stroke in humans.
  • Superior Microvascular Perfusion of Infused Liposome-Encapsulated Hemoglobin Prior to Reductions in Infarctions after Transient Focal Cerebral Ischemia
    Daisuke Shimbo; Takeo Abumiya; Kota Kurisu; Toshiya Osanai; Hideo Shichinohe; Naoki Nakayama; Ken Kazumata; Hideki Nakamura; Hiroshi Shimuzu; Kiyohiro Houkin
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 26, 12, 2994, 3003, 2017年12月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke
    Hideo Shichinohe; Masahito Kawabori; Hiroaki Iijima; Tuyoshi Teramoto; Takeo Abumiya; Naoki Nakayama; Ken Kazumata; Shunsuke Terasaka; Teruyo Arato; Kiyohiro Houkin
    BMC NEUROLOGY, 17, 1, 179, 2017年09月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease
    Ken Kazumata; Khin Khin Tha; Haruto Uchino; Tohru Shiga; Hideo Shichinohe; Masaki Ito; Naoki Nakayama; Takeo Abumiya
    JOURNAL OF NEUROSURGERY, 127, 2, 260, 269, 2017年08月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Surgical Outcome of Cerebral Aneurysm Clipping Treated with Immunosuppressants: Report of 11 Cases and Review of the Literature
    Masaaki Hokari; Naoki Nakayama; Ken Kazumata; Toshiya Osanai; Hideo Shichinohe; Takeo Abumiya; Kiyohiro Houkin
    NEUROLOGIA MEDICO-CHIRURGICA, 57, 3, 122, 127, 2017年03月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Application of cell sheet technology to bone marrow stromal cell transplantation for rat brain infarct
    Masaki Ito; Hideo Shichinohe; Kiyohiro Houkin; Satoshi Kuroda
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 11, 2, 375, 381, 2017年02月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Functional bio-imaging
    Hisayasu Saito; Michiyuki Miyamoto; Hideo Shichinohe; Kiyohiro Houkin; Satoshi Kuroda
    Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials, 111, 119, Springer Japan, 2017年01月01日, [査読有り]
    英語, 論文集(書籍)内論文
  • Cell therapy for ischemic stroke with bone marrow stromal cells
    Satoshi Kuroda; Hideo Shichinohe; Kiyohiro Houkin
    Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials, 15, 25, Springer Japan, 2017年01月01日, [査読有り]
    英語, 論文集(書籍)内論文
  • Ultrasound-guided Femoral Artery Access for Minimally Invasive Neuro-intervention and Risk Factors for Access Site Hematoma.
    Kurisu K; Osanai T; Kazumata K; Nakayama N; Abumiya T; Shichinohe H; Shimoda Y; Houkin K
    Neurologia medico-chirurgica, 56, 12, 745, 752, 2016年12月, [査読有り], [国内誌]
    英語, 研究論文(学術雑誌), Although ultrasound (US) guidance for venous access is becoming the "standard of care" for preventing access site complications, its feasibility for arterial access has not been fully investigated, especially in the neuro-interventional population. We conducted the first prospective cohort study on US-guided femoral artery access during neuro-interventional procedure. This study included 64 consecutive patients who underwent US-guided femoral artery access through 66 arterial access sites for diagnostic and/or neuro-interventional purposes. The number of attempts required for both the sheath insertion and the success of anterior wall puncture were recorded. In addition, the occurrence of major complications and hematoma formation on the arterial access site examined by US were statistically analyzed. The median number of attempts was 1 (1-2) and first-pass success rate was 63.6%. Anterior wall puncture was achieved in 98.5%. In one case (1.5%), a pseudoaneurysm was observed. In all cases, US clearly depicted a common femoral artery (CFA) and its bifurcation. Post-procedural hematoma was detected in 13 cases (19.7%), most of which were "tiny" or "moderate" in size. Low body mass index and antiplatelet therapy were the independent risk factors for access site hematoma. The US-guided CFA access was feasible even in neuro-interventional procedure. The method was particularly helpful in the patients with un-palpable pulsation of femoral arteries. To prevent arterial access site hematoma, special care should be taken in patients with low body mass index and who are on antiplatelet therapy.
  • Increased Blood Viscosity in Ischemic Stroke Patients with Small Artery Occlusion Measured by an Electromagnetic Spinning Sphere Viscometer.
    Furukawa K; Abumiya T; Sakai K; Hirano M; Osanai T; Shichinohe H; Nakayama N; Kazumata K; Hida K; Houkin K
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 25, 11, 2762, 2769, Elsevier, 2016年11月, [査読有り]
    英語, Background and Purpose: High blood viscosity causes blood stagnation and subsequent pathological thrombotic events, resulting in the development of ischemic stroke. We hypothesize that the contribution of blood viscosity may differ among ischemic stroke subtypes based on specific pathological conditions. We tried to verify this hypothesis by measuring blood viscosity in acute ischemic stroke patients using a newly developed electromagnetic spinning sphere (EMS) viscometer. Methods: Measurements in acute ischemic stroke patients were performed 4 times during admission and data were compared with those obtained from 100 healthy outpatient volunteers. Results: We enrolled 92 patients (cardioembolism [CE]: 25, large-artery atherosclerosis [LAA]: 42, and small artery occlusion [SAO]: 25) in this study. Comparisons of blood viscosity between the ischemic stroke subgroups and control group revealed that blood viscosity at the date of admission was significantly higher in the SAO group (5.37±1.11 mPa・s) than in the control group (4.66±0.72 mPa・s) (p<0.01). Among all subtype groups showing a reduction in blood viscosity after 2 weeks, the SAO group showed the highest and most significant reduction, indicating that SAO patients had the most concentrated blood at the onset. Conclusions: Blood viscosity was significantly increased in the SAO group at the date of admission, which indicated the contribution of dehydration to the onset of ischemic stroke. The importance of dehydration needs to be emphasized more in the pathogenesis of SAO. The clinical application of the EMS viscometer is promising for understanding and differentiating the pathogenesis of ischemic stroke.
  • Transarterial regional hypothermia provides robust neuroprotection in a rat model of permanent middle cerebral artery occlusion with transient collateral hypoperfusion.
    Kurisu K; Abumiya T; Ito M; Gekka M; Osanai T; Shichinohe H; Nakayama N; Kazumata K; Houkin K
    Brain research, 1651, 95, 103, 2016年11月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), The robust neuroprotective effects of transarterial regional hypothermia have been demonstrated in the typical transient middle cerebral artery occlusion (tMCAO) model, but have not yet been tested in other ischemic stroke models, even though clinical ischemic conditions are diverse. In order to clarify these effects in a different ischemic stroke model, we employed a rat model of permanent MCAO (pMCAO) with transient collateral hypoperfusion (tCHP), which was achieved by direct MCA ligation through craniotomy and 1-h bilateral common carotid artery occlusion at the beginning of pMCAO. The infusion of 20ml/kg of 4°C cold saline (CS) or 37°C warm saline (WS) into the ipsilateral internal carotid artery (ICA) was performed for 15min in intra- or post-tCHP. Neurological scores, infarct/edema volumes, and neuronal apoptosis and reactive gliosis were compared between the CS and WS groups and a non-infusion control group after 48h of reperfusion. Although brain temperatures were only reduced by 2-3°C for 15min, the CS group had significantly better neurological scores, smaller infarct/edema volumes, and less penumbral neuronal apoptosis and reactive gliosis than the control and WS groups. The post-tCHP CS group exhibited prominent neuroprotective effects, even though infarct volumes and neuronal apoptosis were reduced less than those in the intra-tCHP CS group. In conclusion, we demonstrated the neuroprotective effects of transarterial regional hypothermia in an ischemic model of pMCAO with tCHP. Even though MCAO is persistent, cold infusion via the ICA is neuroprotective for the penumbra, suggesting the wider therapeutic application of this therapy.
  • Cell Therapy for Stroke: Review of Previous Clinical Trials and Introduction of Our New Trials.
    Shichinohe H; Houkin K
    Neurologia medico-chirurgica, 56, 10, 592, 596, 2016年10月, [査読有り], [国内誌]
    英語, 研究論文(学術雑誌), Stroke is still a leading cause of death and disability, and despite intensive research, few treatment options exist. A recent breakthrough in cell therapy is expected to reverse the neurological sequelae of stroke. Although some pioneer studies on the use of cell therapy for the treatment of stroke have been reported, certain problems still remain unsolved. We investigated the use of autologous bone marrow stromal cell (BMSC) transplantation for the treatment of stroke, to develop it as the next-generation cell therapy. In this study, we introduce the preparation of a new clinical trial, the Research on Advanced Intervention using Novel Bone marrow stem cell (RAINBOW) study. The trial will start in 2016, and we hope that it will not only be helpful for treating patients but also for clarifying the therapeutic mechanisms. Moreover, we review stem cell therapeutics as an emerging paradigm in stroke (STEPS) and the guidelines for the development of cell therapy for stroke in the United States as well as introduce the development of new guidelines in Japan. These guidelines are expected to encourage the development of cell therapy for stroke management.
  • Measurement of human blood viscosity by an electromagnetic spinning sphere viscometer.
    Furukawa K; Abumiya T; Sakai K; Hirano M; Osanai T; Shichinohe H; Nakayama N; Kazumata K; Aida T; Houkin K
    Journal of medical engineering & technology, 40, 6, 285, 292, 2016年08月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), We herein applied an electromagnetic spinning sphere (EMS) viscometer to the measurement of human blood viscosity for the first time. We collected blood samples from 100 healthy outpatient volunteers in order to analyse viscosity dependence on blood cell parameters and on the shear rate with a simple approximation formula [ηi (γ)\, = Ai γ(- pi) + η0]. Viscosity dependence on blood cell parameters was relatively high at a high shear rate, but became lower as the shear rate decreased. The approximation formula with appropriate parameters of Ai and pi nearly faithfully reproduced actual blood rheological behaviour with a standard deviation of 1.5%. The distributions of Ai and pi values were broad, suggesting that the pattern of viscosity dependence on the shear rate varied with individual differences. The results obtained using the EMS viscometer suggest that blood viscosity values are individual-specific and actual individual measurements are important for understanding rheological conditions.
  • Transarterial Regional Brain Hypothermia Inhibits Acute Aquaporin-4 Surge and Sequential Microvascular Events in Ischemia/Reperfusion Injury.
    Kurisu K; Abumiya T; Nakamura H; Shimbo D; Shichinohe H; Nakayama N; Kazumata K; Shimizu H; Houkin K
    Neurosurgery, 79, 1, 125, 134, 2016年07月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Although transarterial regional hypothermia is an attractive alternative to general hypothermia, its efficacy and underlying mechanisms remain unclear. OBJECTIVE: To confirm transarterial regional hypothermia therapeutic effects on ischemia/reperfusion (I/R) injury and to elucidate the mechanisms responsible. METHODS: The therapeutic effects of transarterial regional hypothermia were initially investigated in 2-hour middle cerebral artery occlusion rats regionally infused with 10°C saline (cold saline group) or 37°C saline (warm saline group) and untreated rats (control group) just before the onset of 24 hours of reperfusion. The time course of infarct and edema progression, inflammatory reactions, microvascular morphological changes, and aquaporin-4 (AQP4) expression was analyzed after 0, 2, 6, and 24 hours of reperfusion. RESULTS: Cold saline infusion only lowered brain temperatures for 30 minutes but mediated strong neuroprotective effects with infarct volume reductions of less than one-third. The time-course analysis revealed the following sequence of ischemia/reperfusion injury-related events in the control group: upregulated expression of AQP4 (2 hours); microvascular narrowing resulting from swollen astrocytic end-feet (2-6 hours); infarct and edema progression, blood-brain barrier disruption, and upregulated expression of intracellular adhesion molecule-1 (6-24 hours); and the activation of other inflammatory reactions (24 hours). These sequential events were inhibited in the cold saline group. CONCLUSION: Transarterial regional hypothermia initially inhibited the acute AQP4 surge and then attenuated microvascular narrowing, blood-brain barrier disruption, and activation of other inflammatory reactions, leading to strong neuroprotective effects. More direct and intensive cooling of the endothelium and its surroundings may contribute to these effects. ABBREVIATIONS: AQP4, aquaporin-4BBB, blood-brain barrierIba1, ionized calcium-binding adapter molecule 1ICA, internal carotid arteryICAM-1, intracellular adhesion molecule-1I/R, ischemia/reperfusionMCAO, middle cerebral artery occlusionMMP-9, matrix metalloproteinase-9.
  • Investigating Brain Network Characteristics Interrupted by Covert White Matter Injury in Patients with Moyamoya Disease: Insights from Graph Theoretical Analysis
    Kazumata K; Tha K.K; Narita H; Shichinohe H; Ito M; Uchino H; Abumiya T
    World Neurosurgery, 89, 654, 665.e2, 2016年05月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • De novo arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia.
    Shimoda Y; Osanai T; Nakayama N; Ushikoshi S; Hokari M; Shichinohe H; Abumiya T; Kazumata K; Houkin K
    Journal of neurosurgery. Pediatrics, 17, 3, 330, 335, 2016年03月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant systemic disorder characterized by the enlargement of capillaries, recurrent nosebleeds, and multiple arteriovenous malformations (AVMs). Although cerebral AVMs are traditionally considered to be congenital lesions, some reports have described de novo AVMs, which suggests that the authors believed them to be dynamic conditions. In this article, the authors describe the case of a 5-year-old boy with HHT in whom a de novo cerebral AVM was detected after a negative MRI result at 5 months. To the authors' knowledge, this is the first report of a de novo AVM in a patient with HHT. In patients with a family history of HHT, de novo AVMs are possible, even when no lesions are detected at the first screening. Therefore, regular screenings need to be performed, and the family should be informed that AVMs could still develop despite normal MRI results.
  • A Novel Large Cerebral Aneurysm Model in Rats with Intraperitoneal Administration of Beta-Amino Propio Nitril-Fumarate.
    Shimoda Yusuke; Moriwaki Takuya; Nakayama Naoki; Abumiya Takeo; Kazumata Ken; Shichinohe Hideo; Houkin Kiyohiro
    STROKE, 47, 2016年02月, [査読有り]
  • New Clinical Application of Measurement of Blood Viscosity With an Electromagnetically Spinning Sphere Viscometer in Acute Ischemic Stroke Patients
    Abumiya Takeo; Furukawa Koji; Sakai Keiji; Hirano Miki; Osanai Toshiya; Shichinohe Hideo; Nakayama Naoki; Kazumata Ken; Aida Toshimitsu; Houkin Kiyohiro
    STROKE, 47, 2016年02月, [査読有り]
  • The Next Generation of Autologous Bone Marrow Stromal Cell Transplantation Against Stroke
    Shichinohe Hideo; Tan Chengbo; Saito Hisayasu; Miyamoto Michiyuki; Hamauchi Shuji; Abumiya Takeo; Nakayama Naoki; Kazumata Ken; Houkin Kiyohiro; Kuroda Satoshi
    STROKE, 47, 2016年02月, [査読有り]
  • Trans-arterial Regional Hypothermia Provides Robust Neuroprotection in Rat Permanent Middle Cerebral Artery Occlusion Model
    Kurisu Kota; Abumiya Takeo; Ito Masaki; Shichinohe Hideo; Nakayama Naoki; Kazumata Ken; Osanai Toshiya; Houkin Kiyohiro
    STROKE, 47, 2016年02月, [査読有り]
  • Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke
    Chengbo Tan; Hideo Shichinohe; Zifeng Wang; Shuji Hamauchi; Takeo Abumiya; Naoki Nakayama; Ken Kazumata; Tsuneo Ito; Kohsuke Kudo; Shigeru Takamoto; Kiyohiro Houkin
    Stem Cells International, 2016, Hindawi Limited, 2016年, [査読有り]
    英語, 研究論文(学術雑誌)
  • [Efficacy of Stent-Assisted Coil Embolization for a Dissecting Aneurysm of the Cervical Internal Carotid Artery Caused by a Systemic Vascular Disease: A Case Report].
    Takamiya S; Osanai T; Ushikoshi S; Kurisu K; Shimoda Y; Ito Y; Ishi Y; Hokari M; Nakayama N; Kazumata K; Abumiya T; Shichinohe H; Houkin K
    No shinkei geka. Neurological surgery, 44, 1, 39, 45, 2016年01月, [査読有り], [国内誌]
    日本語, 研究論文(学術雑誌), Systemic vascular diseases such as fibromuscular dysplasia, Ehlers-Danlos syndrome, Marfan syndrome, and Behçet's disease are known to cause spontaneous dissecting aneurysms of the cervical internal carotid artery. These diseases are generally associated with vascular fragility; therefore, invasive treatments are avoided in many cases of dissecting aneurysms, and a conservative approach is used for the primary disease. Surgical or intravascular treatment may be chosen when aneurysms are progressive or are associated with a high risk of hemorrhage; however, there is no consensus on which treatment is better. We report a case of a dissecting aneurysm of the cervical internal carotid artery in a patient with suspected Behçet's disease, which was treated using stent-assisted coil embolization. A man in his 40's, with suspected Behçet's disease, presented with an enlarged dissecting aneurysm of the right cervical internal carotid artery. The lesion was present for approximately 10 years. We performed stent-assisted coil embolization for the lesion. Post-surgery, no aneurysms were detected with carotid artery echography. Our case report suggests that stent-assisted coil embolization is a promising treatment for dissecting aneurysms of the cervical internal carotid artery. In addition, the procedure demonstrates the utility of carotid artery echograms for examining recanalization after stent-assisted coil embolization.
  • Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells.
    Hamauchi S; Shichinohe H; Uchino H; Yamaguchi S; Nakayama N; Kazumata K; Osanai T; Abumiya T; Houkin K; Era T
    PloS one, 11, 9, e0163561, 2016年, [査読有り]
    英語, 研究論文(学術雑誌)
  • Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke.
    Tan C; Shichinohe H; Wang Z; Hamauchi S; Abumiya T; Nakayama N; Kazumata K; Ito T; Kudo K; Takamoto S; Houkin K
    Stem cells international, 2016, 6104780, 6104780, 2016年, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • Characteristics of Diffusional kurtosis in chronic ischemia of adult Moyamoya disease: Comparing Diffusional kurtosis and diffusion tensor imaging
    Kazumata K; Tha K.K; Narita H; Ito Y.M; Shichinohe H; Ito M; Uchino H; Abumiya T
    American Journal of Neuroradiology, 37, 8, 1432, 1439, 2016年, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • Inside Intramural Thrombus Formation with Inflammatory Reactions is Relevant to the Rupture of Cerebral Aneurysms
    Shimoda Yusuke; Nakayama Naoki; Hokari Masaaki; Abumiya Takeo; Shichinohe Hideo; Kazumata Ken; Houkin Kiyohiro
    JOURNAL OF NEUROSURGERY, 123, 2, A526, 2015年08月, [査読有り]
  • Surgical Outcomes for Cervical Carotid Artery Stenosis: Treatment Strategy for Bilateral Cervical Carotid Artery Stenosis.
    Hokari M; Nakayama N; Kazumata K; Osanai T; Nakamura T; Yasuda H; Ushikoshi S; Shichinohe H; Abumiya T; Kuroda S; Houkin K
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 24, 8, 1768, 1774, 2015年08月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Carotid endarterectomy (CEA) and carotid stenting (CAS) are beneficial procedures for patients with high-grade cervical carotid stenosis. However, it is sometimes difficult to manage patients with bilateral carotid stenosis. To decide the treatment strategy, one of the most important questions is whether contralateral stenosis increases the risk of patients undergoing CEA. METHODS: This retrospective study included 201 patients with carotid stenosis who underwent a total of 219 consecutive procedures (CEA 189/CAS 30). We retrospectively analyzed outcomes in patients with carotid stenosis who were treated with either CEA or CAS and evaluated whether or not contralateral lesions increases the risk of patients undergoing CEA or CAS. Furthermore, we retrospectively verified our treatment strategy for bilateral carotid stenosis. RESULTS: The incidences of perioperative complications were 5.3% in the CEA patients and 6.7% in the CAS patients, respectively. There was no significant difference between these 2 groups. The existences of contralateral occlusion and/or contralateral stenosis were not associated with perioperative complications in both the groups. There were 32 patients with bilateral severe carotid stenosis (>50%). Of those, 13 patients underwent bilateral revascularizations; CEA followed by CEA in 8, CEA followed by CAS in 3, CAS followed by CEA + coronary artery bpass grafting in 1, and CAS followed by CAS in 1. CONCLUSIONS: Our date showed that the existence of contralateral carotid lesion was not associated with perioperative complications, and most of our cases with bilateral carotid stenosis initially underwent CEA.
  • Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia.
    Shichinohe H; Tan C; Abumiya T; Nakayama N; Kazumata K; Hokari M; Houkin K; Kuroda S
    Brain research, 1602, 53, 61, 2015年03月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), The phosphodiesterase (PDE) 3 inhibitor cilostazol, used as an anti-platelet drug, reportedly can also ameliorate ischemic brain injury. Here, we investigated the effects of cilostazol in a permanent focal ischemia mice model. Male Balb/c mice were subjected to permanent middle cerebral artery occlusion. Mice were then treated with either cilostazol (10 or 20mg/kg) or vehicle administered at 30min and 24h post-ischemia, and infarct volumes were assessed at 48h post-ischemia. Mice treated with 20mg/kg of cilostazol or vehicle were sacrificed at 6h or 24h post-ischemia and immunohistochemistry was used for brain sections. Treatment with 20mg/kg of cilostazol significantly reduced infarct volumes to 70.1% of those with vehicle treatment. Immunohistochemistry results for 8-hydroxydeoxyguanosine (OHdG) expression showed that some neurons underwent oxidative stress around the ischemic boundary zone at 6h post-ischemia. Cilostazol treatment significantly reduced the percentage of 8-OHdG-positive neurons (65.8±33.5% with vehicle and 21.3±9.9% with cilostazol). Moreover, NADPH oxidase (NOX) 2-positive neurons were significantly reduced with cilostazol treatment. In contrast, immunohistochemistry results for phosphorylated cyclic-AMP response element binding protein (pCREB) showed that there were significantly more pCREB-positive neurons around the ischemic boundary zone of cilostazol-treated mice than in those of vehicle-treated mice at 24h post-ischemia. These results suggested that cilostazol might have multiple mechanisms of action to ameliorate ischemic tissue damage, by attenuating oxidative stress mediated by suppressing NOX2 expression by ischemic neurons and an anti-apoptotic effect mediated through the pCREB pathway.
  • Cilostazol Can Attenuate Oxidative Stress by Suppressing Nox2 on Neurons in Mice Permanent Focal Ischemia
    Shichinohe Hideo; Kuroda Satoshi; Tan Chengbo; Abumiya Takeo; Nakayama Naoki; Kazumata Ken; Hokari Masaaki; Houkin Kiyohiro
    STROKE, 46, 2015年02月, [査読有り]
  • Inside Intramural Thrombus Formation with Inflammatory Reactions Is Relevant to the Rupture of Cerebral Aneurysms
    Shimoda Yusuke; Nakayama Naoki; Hokari Masaaki; Abumiya Takeo; Shichinohe Hideo; Kazumata Ken; Houkin Kiyohiro
    STROKE, 46, 2015年02月, [査読有り]
  • Post-ischemic Trans-arterial Regional Hypothermia Therapy Attenuates Microvascular Narrowing due to Astrocyte End-feet Swelling and Inhibits Subsequent Inflammatory Reactions in Ischemia Reperfusion Injury
    Kurisu Kota; Abumiya Takeo; Nakamura Hideki; Shimbo Daisuke; Kazumata Ken; Nakayama Naoki; Shichinohe Hideo; Hokari Masaaki; Osanai Toshiya; Shimizu Hiroshi; Houkin Kiyohiro
    STROKE, 46, 2015年02月, [査読有り]
  • Utility of 4D-MRA to Measure Blood Flow Velocity in Cerebral Major Arteries
    Abumiya Takeo; Fujima Noriyuki; Kudo Kohsuke; Ishi Yukitomo; Gekka Masayuki; Shichinohe Hideo; Kazumata Ken; Nakayama Naoki; Houkin Kiyohiro
    STROKE, 46, 2015年02月, [査読有り]
  • Chronic ischemia alters brain microstructural integrity and cognitive performance in adult moyamoya disease.
    Kazumata K; Tha KK; Narita H; Kusumi I; Shichinohe H; Ito M; Nakayama N; Houkin K
    Stroke, 46, 2, 354, 360, 2015年02月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • Therapeutic Effects of Human Multilineage-Differentiating Stress Enduring (MUSE) Cell Transplantation into Infarct Brain of Mice.
    Yamauchi T; Kuroda Y; Morita T; Shichinohe H; Houkin K; Dezawa M; Kuroda S
    PloS one, 10, 3, e0116009, 3, 2015年, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), OBJECTIVE: Bone marrow stromal cells (BMSCs) are heterogeneous and their therapeutic effect is pleiotropic. Multilineage-differentiating stress enduring (Muse) cells are recently identified to comprise several percentages of BMSCs, being able to differentiate into triploblastic lineages including neuronal cells and act as tissue repair cells. This study was aimed to clarify how Muse and non-Muse cells in BMSCs contribute to functional recovery after ischemic stroke. METHODS: Human BMSCs were separated into stage specific embryonic antigen-3-positive Muse cells and -negative non-Muse cells. Immunodeficient mice were subjected to permanent middle cerebral artery occlusion and received transplantation of vehicle, Muse, non-Muse or BMSCs (2.5×104 cells) into the ipsilateral striatum 7 days later. RESULTS: Motor function recovery in BMSC and non-Muse groups became apparent at 21 days after transplantation, but reached the plateau thereafter. In Muse group, functional recovery was not observed for up to 28 days post-transplantation, but became apparent at 35 days post-transplantation. On immunohistochemistry, only Muse cells were integrated into peri-infarct cortex and differentiate into Tuj-1- and NeuN-expressing cells, while negligible number of BMSCs and non-Muse cells remained in the peri-infarct area at 42 days post-transplantation. CONCLUSIONS: These findings strongly suggest that Muse cells and non-Muse cells may contribute differently to tissue regeneration and functional recovery. Muse cells may be more responsible for replacement of the lost neurons through their integration into the peri-infarct cortex and spontaneous differentiation into neuronal marker-positive cells. Non-Muse cells do not remain in the host brain and may exhibit trophic effects rather than cell replacement.
  • Platelet lysate and granulocyte-colony stimulating factor serve safe and accelerated expansion of human bone marrow stromal cells for stroke therapy.
    Yamauchi T; Saito H; Ito M; Shichinohe H; Houkin K; Kuroda S
    Translational stroke research, 5, 6, 701, 710, 2014年12月, [査読有り]
    英語, 研究論文(学術雑誌)
  • 脳卒中再生医療 脳梗塞をターゲットとした自己骨髄間質細胞の定位移植治療
    黒田 敏; 七戸 秀夫; 宝金 清博; 出澤 真理
    脳循環代謝, 26, 1, 103, 103, (一社)日本脳循環代謝学会, 2014年11月
    日本語
  • Short-, middle- and long-term safety of superparamagnetic iron oxide-labeled allogeneic bone marrow stromal cell transplantation in rat model of lacunar infarction.
    Tan C; Shichinohe H; Abumiya T; Nakayama N; Kazumata K; Hokari M; Hamauchi S; Houkin K
    Neuropathology : official journal of the Japanese Society of Neuropathology, 35, 3, 197, 208, 2014年11月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Recently, both basic and clinical studies demonstrated that bone marrow stromal cell (BMSC) transplantation therapy can promote functional recovery of patients with CNS disorders. A non-invasive method for cell tracking using MRI and superparamagnetic iron oxide (SPIO)-based labeling agents has been applied to elucidate the behavior of transplanted cells. However, the long-term safety of SPIO-labeled BMSCs still remains unclear. The aim of this study was to investigate the short-, middle- and long-term safety of the SPIO-labeled allogeneic BMSC transplantation. For this purpose, BMSCs were isolated from transgenic rats expressing green fluorescent protein (GFP) and were labeled with SPIO. The Na/K ATPase pump inhibitor ouabain or vehicle was stereotactically injected into the right striatum of wild-type rats to induce a lacunar lesion (n = 22). Seven days after the insult, either BMSCs or SPIO solution were stereotactically injected into the left striatum. A 7.0-Tesla MRI was performed to serially monitor the behavior of BMSCs in the host brain. The animals were sacrificed after 7 days (n = 7), 6 weeks (n = 6) or 10 months (n = 9) after the transplantation. MRI demonstrated that BMSCs migrated to the damage area through the corpus callosum. Histological analysis showed that activated microglia were present around the bolus of donor cells 7 days after the allogeneic cell transplantation, although an immunosuppressive drug was administered. The SPIO-labeled BMSCs resided and started to proliferate around the route of the cell transplantation. Within 6 weeks, large numbers of SPIO-labeled BMSCs reached the lacunar infarction area from the transplantation region through the corpus callosum. Some SPIO nanoparticles were phagocytized by microglia. After 10 months, the number of SPIO-positive cells was lower compared with the 7-day and 6-week groups. There was no tumorigenesis or severe injury observed in any of the animals. These findings suggest that BMSCs are safe after cell transplantation for the treatment of stroke.
  • Bone Marrow Stromal Cells Rescue Ischemic Brain by Trophic Effects and Phenotypic Change Toward Neural Cells.
    Shichinohe H; Ishihara T; Takahashi K; Tanaka Y; Miyamoto M; Yamauchi T; Saito H; Takemoto H; Houkin K; Kuroda S
    Neurorehabilitation and neural repair, 29, 1, 80, 9, 2014年03月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), Background. Transplantation of bone marrow stromal cells (BMSCs) may contribute to functional recovery after stroke. This study was designed to clarify their mechanisms, trophic effects of neurotrophic factors, and neural differentiation. Methods. Mouse neurons exposed to glutamate were cocultured with mouse BMSCs. Either neutralizing antibodies against brain-derived neurotrophic factor (BDNF) or nerve growth factor (NGF) or Trk inhibitor K252a was added to explore the mechanism of their protective effects. Fluorescence in situ hybridization (FISH) was used to assess BDNF or NGF mRNA expression in BMSCs. The mice were subjected to permanent focal ischemia, and 7 days later, either BMSCs or the vehicle was stereotactically transplanted into the ipsilateral striatum. The mouse brains were processed for FISH and immunostaining 2 or 4 weeks after transplantation. Results. BMSCs significantly ameliorated glutamate-induced neuronal death. Treatment with anti-BDNF antibody significantly reduced their protective effects. FISH analysis showed that the majority of BMSCs expressed BDNF and NGF mRNA in vitro. BMSC transplantation significantly improved the survival of neurons in peri-infarct areas. FISH analysis revealed that approximately half of BMSCs expressed BDNF and NGF mRNA 2 weeks after transplantation; however, the percentage of BDNF and NGF mRNA-positive cells decreased thereafter. Instead, the percentage of microtubule-associated protein 2-positive BMSCs gradually increased during 4 weeks after transplantation. Conclusions. These findings strongly suggest that BDNF may be a key factor underlying the trophic effects of BMSCs. BMSCs might exhibit the trophic effect in the early stage of cell therapy and the phenotypic change toward neural cells thereafter.
  • Post-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin can reduce ischemia reperfusion injury.
    Shimbo D; Abumiya T; Shichinohe H; Nakayama N; Kazumata K; Houkin K
    Brain research, 1554, 59, 66, Elsevier, 2014年03月, [査読有り]
    英語, Despite successful revascularization, reperfusion after prolonged ischemia causes ischemia reperfusion (I/R) injury. Recruitment and activation of neutrophils is thought to be a key event causing I/R injury. We examined whether post-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin (LEH), an artificial oxygen carrier without neutrophils, could reduce I/R injury in a rat transient middle cerebral artery occlusion (MCAO) model. Male Sprague-Dawley rats were subjected to 2-h MCAO and then were divided into three groups: (1) LEH group (n=7) infused with LEH (Hb concentration of 6 g/dl, 10 ml/kg/h) through the recanalized internal carotid artery for 2 h, (2) vehicle group (n=8) infused with saline (10 ml/kg/h) in the same manner as the LEH group, and (3) control group (n=9) subjected to recanalization only. After 24-h reperfusion, all rats were tested for neurological score and then sacrificed to examine infarct and edema volumes, myeloperoxidase (MPO) expression, matrix metalloproteinase-9 (MMP-9) expression and activity, and reactive oxygen species (ROS) production. Compared with the control group and the vehicle group, the LEH group showed a significantly better neurological score and significantly smaller infarct and edema volumes. MPO expression, MMP-9 expression and activity, and ROS production in the LEH group were also significantly lower than those in the control and vehicle groups. The results in the present study suggest that post-ischemic intra-arterial infusion of LEH can reduce I/R injury through reducing the effect of MMP-9, most likely produced by neutrophils. This therapeutic strategy may be a promising candidate to prevent I/R injury after thrombolysis and/or thromboectomy. (C) 2014 Elsevier B.V. All rights reserved.
  • Spatial Relationship between Cerebral Microbleeds, Moyamoya Vessels, and Hematoma in Moyamoya Disease.
    Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 23, 6, 1421, 8, 2014年02月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Adult moyamoya disease (MMD) is known to have high incidence of cerebral microbleeds (cMBs); however, the clinical significance still remains unclear. We investigated the frequency of cMBs in a large number of patients and analyzed the patterns of MB distribution in association with the location of the hematoma and moyamoya vessels. METHODS: We studied 259 consecutive patients with MMD using prospectively collected database. One hundred ninety-one patients were eligible for the present study, and image analysis was performed retrospectively. The presence of cMBs and remains of hemorrhage were determined using gradient-echo T2*-weighted sequence (1.5 T). The development of moyamoya vessels was assessed on source images of time-of-flight magnetic resonance angiography. The analysis consists of descriptive assessment of the spatial relationship between cMB, remains of hemorrhage, and moyamoya vessels. Statistical analysis was performed to calculate relative risk ratio in the presence of cMBs in relation to the remains of hemorrhage (macrohematoma), age of onset, and the presence of concomitant moyamoya vessels. RESULTS: Thirty MBs were observed in 20 adult MMD patients (16.9%). MBs were located predominantly in the periventricular white matter (63.3%) followed by the basal ganglia/thalami (20%). Comparing the patients with cMBs from those without, hematoma was more frequently observed in patients with cMBs (odds ratio [OR] 4.29; 95% confidence interval [CI] 1.58-11.62; P=.0062). Patients with adult onset was more likely to demonstrate cMBs (14.4%) compared with the patients with pediatric onset (4.1%) (OR 3.93; 95% CI 1.11-13.91). Moyamoya vessels appeared in the lateral part of the trigon, and the periventricular white matter was significantly associated with the presence of cMBs (lateral part of the trigon; OR 3.29 [1.59-6.82], P=.0019, periventricle of the body of lateral ventricle; OR 2.40 [1.20-4.79], P=.0214, respectively). cMBs accompanied concomitant arteries in 23 (76.7%) lesions. The subependymal-leptomeningeal artery anastomosis was the most common pattern (n=20, 66.7%). CONCLUSIONS: Spatial relationship was demonstrated between the moyamoya vessels and perivascular hemosiderin deposition particularly around the subependymal-leptomeningeal anastomosis, suggesting the mechanism for the development of cMBs in MMD. Present study further supports previous findings that cMBs potentially serve as a marker for the bleeding-prone microangiopathy in MMD. The significance of the present study lies in selecting optimal surgical candidate for preventing future hemorrhage by the presence of the cMBs, whereas current surgical indication relying on the degree of ischemia frequently fails to detect patients with future hemorrhage.
  • Ivy sign, misery perfusion, and asymptomatic moyamoya disease: FLAIR imaging and (15)O-gas positron emission tomography.
    Vuignier S; Ito M; Kurisu K; Kazumata K; Nakayama N; Shichinohe H; Shiga T; Kiss JZ; Tamaki N; Houkin K
    Acta neurochirurgica, 155, 11, 2097, 2104, 2013年11月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: The prevalence of ivy sign on fluid-attenuated inversion recovery (FLAIR) imaging in patients with asymptomatic moyamoya disease is unclear. The aim of this study was to clarify the incidence of ivy sign in these patients, as well as the correlation between MRI and (15)O gas PET findings. METHODS: A retrospective analysis including 16 consecutive patients with asymptomatic moyamoya disease enrolled between 2001 and 2010 in a single center. FLAIR imaging at the initial visit was categorized as ivy sign present, negative, or equivocal. Hemodynamic and metabolic parameters were quantified in 11 of 16 patients by (15)O-gas positron emission tomography, and the relationship between ivy sign and (15)O-gas PET parameters was analyzed. Cerebrovascular events within the follow-up period (54 ± 28 months) were also examined. RESULTS: Five of 16 asymptomatic moyamoya patients (31.3 %) had positive ivy sign (6/30 hemispheres, 20 %). In (15)O-gas PET examinations, 18 % of 22 hemispheres had elevated oxygen extraction fraction values that were significantly associated with positive ivy sign. Of these 16 asymptomatic moyamoya patients, six patients (37.5 %) underwent combined surgical revascularization. In this series, no patients experienced ischemic stroke, but one had intraventricular bleeding 1 year after surgery. CONCLUSIONS: Ivy sign on FLAIR imaging is still not rare in patients with moyamoya disease, even when asymptomatic. Although optimal management is still under debate, ivy sign may be an indicator of misery perfusion, and patients with asymptomatic moyamoya disease and ivy sign on FLAIR imaging will benefit from more careful follow-up.
  • 123I-Iomazenil Single Photon Emission Computed Tomography Visualizes Recovery of Neuronal Integrity by Bone Marrow Stromal Cell Therapy in Rat Infarct Brain.
    Saito H; Magota K; Zhao S; Kubo N; Kuge Y; Shichinohe H; Houkin K; Tamaki N; Kuroda S
    Stroke, 44, 10, 2869, 2874, 2013年10月, [査読有り], [国際誌]
    英語, 研究論文(その他学術会議資料等), BACKGROUND AND PURPOSE: This study was aimed to assess whether (123)I-iomazenil (IMZ) single photon emission computed tomography can serially monitor the effects of bone marrow stromal cell (BMSC) transplantation on neuronal integrity in infarct brain of rats. METHODS: The BMSCs were harvested from green fluorescent protein-transgenic rats and were cultured. The rats were subjected to permanent middle cerebral artery occlusion. Their motor function was serially quantified throughout the experiments. The BMSCs or vehicle was stereotactically transplanted into the ipsilateral striatum at 7 days after the insult. Using small-animal single photon emission computed tomography/computed tomography apparatus, the (123)I-IMZ uptake was serially measured at 6 and 35 days after the insult. Finally, fluorescence immunohistochemistry was performed to evaluate the distribution of engrafted cells and their phenotypes. RESULTS: The distribution of (123)I-IMZ was markedly decreased in the ipsilateral neocortex at 6 days postischemia. The vehicle-transplanted animals did not show a significant change at 35 days postischemia. However, BMSC transplantation significantly improved the distribution of (123)I-IMZ in the peri-infarct neocortex as well as motor function. The engrafted BMSCs were densely distributed around cerebral infarct, and some of them expressed neuronal nuclear antigen and γ-aminobutyric acid type-A receptor. CONCLUSIONS: The present findings strongly suggest that the BMSCs may enhance functional recovery by improving the neuronal integrity in the peri-infarct area, when directly transplanted into the infarct brain at clinically relevant timing. (123)I-IMZ single photon emission computed tomography may be a promising modality to scientifically prove the beneficial effects of BMSC transplantation on the host brain in clinical situation.
  • Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct
    Masahito Kawabori; Satoshi Kuroda; Masaki Ito; Hideo Shichinohe; Kiyohiro Houkin; Yuji Kuge; Nagara Tamaki
    NEUROPATHOLOGY, 33, 2, 140, 148, 2013年04月, [査読有り]
    英語, 研究論文(学術雑誌)
  • 骨髄間質細胞移植によるラクナ梗塞モデルの中枢神経再生
    七戸秀夫; 黒田敏; 宮本倫行; 山内朋裕; 斎藤久泰; 新保大輔; 数又研; 中山若樹; 寶金清博
    再生医療, 12, 237, 2013年02月28日
    日本語
  • Post-ischemic Intra-arterial Infusion of Liposome-encapsulated Hemoglobin Can Reduce Ischemic Reperfusion Injury
    Shimbo Daisuke; Abumiya Takeo; Shichinohe Hideo; Nakayama Naoki; Kazumata Ken; Houkin Kiyohiro; Ishizuka Takanobu
    STROKE, 44, 2, 2013年02月, [査読有り]
  • Impaired Cerebrovascular Reactivity to Acetazolamide in Parent Arterial Territory of Major Artery Aneurysms in Adult Patients with Moyamoya Disease
    Ito Masaki; Houkin Kiyohiro; Niiya Yoshimasa; Uchino Haruto; Mabuchi Shoji; Nakayama Naoki; Kazumata Ken; Shichinohe Hideo; Sugiyama Taku; Ishii Nobuaki; Nomura Mikio
    STROKE, 44, 2, 2013年02月, [査読有り]
  • Bone marrow stromal cell transplantation enhances recovery of local glucose metabolism after cerebral infarction in rats: A serial 18F-FDG PET study
    Michiyuki Miyamoto; Satoshi Kuroda; Songji Zhao; Keiichi Magota; Hideo Shichinohe; Kiyohiro Houkin; Yuji Kuge; Nagara Tamaki
    Journal of Nuclear Medicine, 54, 1, 145, 150, 2013年01月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Bone marrow stromal cell transplantation enhances recovery of motor function after lacunar stroke in rats.
    Shichinohe H; Yamauchi T; Saito H; Houkin K; Kuroda S
    Acta neurobiologiae experimentalis, 73, 3, 354, 363, 3, 2013年, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), This study was aimed to clarify if the bone marrow stromal cells (BMSCs) significantly improve functional outcome after lacunar stroke when stereotactically transplanted into the brain. Ouabain, a Na/K ATPase pump inhibitor, was stereotactically injected into the right striatum of Wistar rats. One week later, the superparamagnetic iron oxide (SPIO)-labeled rat BMSCs (n=7) or vehicle (n=8) were stereotactically transplanted into the left striatum. Using rotarod test, motor function was serially evaluated through the experiment. A 7.0-T MR apparatus was employed to serially monitor the migration of BMSCs in the host brain. Histological analysis was performed at 7 weeks after ouabain injection, i.e., 6 weeks after BMSC transplantation. Ouabain injection yielded the reproducible, focal lesion in the right striatum, causing continuous motor dysfunction throughout the experiment. BMSC transplantation significantly enhanced the recovery of motor function after ouabain injection. MR imaging demonstrated that the BMSCs aggressively migrated towards the lesion through the corpus callosum. Histological analysis supported the findings on MRI. The BMSCs significantly enhanced the neurogenesis in the subventricular zone (SVZ) on both sides. Some of them also expressed neuronal or astrocytic phenotypes in the neocortex, SVZ, corpus callosum, and peri-lesion area. These findings strongly suggest that the BMSCs may serve therapeutic impacts on lacunar stroke when stereotactically transplanted at clinically relevant timing.
  • 骨髄間質細胞の動脈内送達の治療効果(Therapeutic effects of intra-arterial delivery of bone marrow stromal cells)
    長内 俊也; 黒田 敏; 七戸 秀夫; 久下 裕司; 玉木 長良; 宝金 清博
    脳循環代謝, 24, 1, 147, 147, (一社)日本脳循環代謝学会, 2012年11月
    日本語
  • Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: An optical imaging study
    Masahito Kawabori; Satoshi Kuroda; Taku Sugiyama; Masaki Ito; Hideo Shichinohe; Kiyohiro Houkin; Yuji Kuge; Nagara Tamaki
    NEUROPATHOLOGY, 32, 3, 217, 226, 2012年06月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Review of Past Research and Current Concepts on the Etiology of Moyamoya Disease
    Kiyohiro Houkin; Masaki Ito; Taku Sugiyama; Hideo Shichinohe; Naoki Nakayama; Ken Kazumata; Satoshi Kuroda
    NEUROLOGIA MEDICO-CHIRURGICA, 52, 5, 267, 277, 2012年05月, [査読有り]
    英語
  • Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: functional enhancement by granulocyte-colony stimulating factor (G-CSF).
    Yasuhiro Chiba; Satoshi Kuroda; Toshiya Osanai; Hideo Shichinohe; Kiyohiro Houkin; Yoshinobu Iwasaki
    Neuropathology : official journal of the Japanese Society of Neuropathology, 32, 2, 139, 48, 2, 2012年04月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), This study was designed to clarify the effects of donor age on biological features of bone marrow stromal cells (BMSC), one of the candidates for cell transplantation therapy for CNS disorders, because many aged patients might require such therapy. This study was also aimed to test whether ex vivo treatments with granulocyte-colony stimulating factor (G-CSF) could modify biological properties of BMSC from aged donors and enhance its therapeutic effects in an animal model of traumatic brain injury. The BMSC were harvested from young (6-week-old) and aged (100-week-old) rats. The ageing significantly increased the senescence-associated β-galactosidase (SA-β-gal) activity of the cultured BMSC, and decreased their proliferative capacity and production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). As the next step, the rats were subjected to brain freezing injury by applying liquid nitrogen onto the neocortex through the thinned skull. The 6-week BMSC, 100-week BMSC, G-CSF-treated 100-week BMSC or vehicle were stereotactically injected into the ipsilateral striatum at 7 days post-injury. Transplantation of the 6-week BMSC, but not 100-week BMSC, significantly improved locomotor function. However, treatment of the 100-week BMSC with 0.1 µmol of G-CSF significantly improved their proliferation activity and growth factor production, and recovered therapeutic effects in the injured brain. In conclusion, donor age may largely determine biological aspects of BMSC. G-CSF may contribute to improve the outcome of BMSC transplantation therapy for CNS disorders in aged patients.
  • Visualization of the Superparamagnetic Iron Oxide (SPIO)-Labeled Bone Marrow Stromal Cells Using a 3.0-T MRI-a Pilot Study for Clinical Testing of Neurotransplantation.
    Shichinohe H; Kuroda S; Kudo K; Ito M; Kawabori M; Miyamoto M; Nakanishi M; Terae S; Houkin K
    Translational stroke research, 3, 1, 99, 106, 2012年03月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌)
  • Therapeutic effects of intra-arterial delivery of bone marrow stromal cells in traumatic brain injury of rats--in vivo cell tracking study by near-infrared fluorescence imaging.
    Toshiya Osanai; Satoshi Kuroda; Taku Sugiyama; Masahito Kawabori; Masaki Ito; Hideo Shichinohe; Yuji Kuge; Kiyohiro Houkin; Nagara Tamaki; Yoshinobu Iwasaki
    Neurosurgery, 70, 2, 435, 44, 2, 2012年02月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: A noninvasive and effective route of cell delivery should be established to yield maximal therapeutic effects for central nervous system (CNS) disorders. OBJECTIVE: To elucidate whether intra-arterial delivery of bone marrow stromal cells (BMSCs) significantly promotes functional recovery in traumatic brain injury (TBI) in rats. METHODS: Rat BMSCs were transplanted through the ipsilateral internal carotid artery 7 days after the onset of cortical freezing injury. The BMSCs were labeled with fluorescent dye, and in vivo optical imaging was employed to monitor the behaviors of cells for 4 weeks after transplantation. Motor function was assessed for 4 weeks, and the transplanted BMSCs were examined using immunohistochemistry. RESULTS: In vivo optical imaging and histologic analysis clearly demonstrated that the intra-arterially injected BMSCs were engrafted during the first pass without systemic circulation, and the transplanted BMSCs started to migrate from the cerebral capillary bed to the injured CNS tissue within 3 hours. Intra-arterial BMSC transplantation significantly promoted functional recovery after cortical freezing injury. A subgroup of BMSCs expressed the phenotypes of neurons, astrocytes, and endothelial cells around the injured neocortex 4 weeks after transplantation. CONCLUSION: Intra-arterial transplantation may be a valuable option for prompt, noninvasive delivery of BMSCs to the injured CNS tissue, enhancing functional recovery after TBI. In vivo optical imaging may provide important information on the intracerebral behaviors of donor cells by noninvasive, serial visualization.
  • Topography of Hemorrhage and Microbleeds in Adult Moyamoya Disease
    Kazumata Ken; Houkin Kiyohiro; Nakayama Naoki; Shichinohe Hideo; Osanai Toshiya; Shinpo Daisuke; Saito Hisayasu
    CEREBROVASCULAR DISEASES, 34, 32, 2012年, [査読有り]
  • Irregular Neointimal Lining with Prominent Proliferative Activity in a Patient Underwent Patch Angioplasty for Carotid Endarterectomy - An Autopsy Case Report
    Ito Masaki; Niiya Yoshimasa; Uchino Haruto; Itosaka Hiroyuki; Shichinohe Hideo; Kazumata Ken; Nakayama Naoki; Mabuchi Syoji; Houkin Kiyohiro
    CEREBROVASCULAR DISEASES, 34, 102, 2012年, [査読有り]
  • 人工酸素運搬体Liposome‐encapsulated hemoglobinを用いた虚血再灌流傷害の治療戦略
    新保大輔; 鐙谷武雄; 七戸秀夫; 中山若樹; 数又研; 宝金清博; 石塚隆伸
    脳循環代謝, 24, 1, 178, 178, (一社)日本脳循環代謝学会, 2012年
    日本語
  • 骨髄間質細胞移植は脳梗塞周囲の神経受容体機能を改善させる―123I‐iomazenil SPECTによる検討
    齋藤久泰; 黒田敏; 宮本倫行; 山内朋裕; 七戸秀夫; 趙松吉; 孫田惠一; 久保直樹; 久下裕司; 玉木長良; 寶金清博
    脳循環代謝, 24, 1, 216, 2012年
    英語, 研究論文(その他学術会議資料等)
  • 骨髄間質細胞移植は脳梗塞後の局所糖代謝を改善する―小動物用PET/CTによる検討
    宮本倫行; 黒田敏; 趙松吉; 孫田恵一; 伊東雅基; 川堀真人; 丸一勝彦; 七戸秀夫; 宝金清博; 久下裕司; 玉木長良
    再生医療, 11, 191, 2012年
    日本語, 研究論文(その他学術会議資料等)
  • 脳梗塞をターゲットとした骨髄間質細胞移植―新たな培養・移植・イメージング技術による展開
    黒田敏; 宮本倫行; 山内朋裕; 斉藤久泰; 伊東雅基; 川堀真人; 杉山拓; 千葉泰弘; 七戸秀夫; 宝金清博; 久下裕司; 趙松吉; 玉木長良
    再生医療, 11, 136, 2012年
    日本語, 研究論文(その他学術会議資料等)
  • Validity of bone marrow stromal cell expansion by animal serum-free medium for cell transplantation therapy of cerebral infarct in rats-a serial MRI study.
    Ito M; Kuroda S; Sugiyama T; Shichinohe H; Takeda Y; Nishio M; Koike T; Houkin K
    Translational stroke research, 2, 3, 294, 306, 2011年09月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), This study was aimed to test the hypothesis that human bone marrow stromal cells (hBMSC) expanded in fetal calf serum (FCS)-free, platelet lysate (PL)-containing medium would retain their capacity of migration, survival, and neural differentiation when transplanted into the infarct brain, using serial in vivo magnetic resonance imaging (MRI). Cell growth kinetic analysis revealed that hBMSC maintain their proliferative activity when cultured either in conventional FCS-containing medium or FCS-free, PL-containing medium. Subsequently, hBMSC were labeled with a superparamagnetic iron oxide agent and were stereotactically transplanted into the ipsilateral striatum of rats at 7 days after permanent middle cerebral artery occlusion. Serial MRI performed over 8 weeks revealed that they retain their migratory capacity towards the cerebral infarct. Moreover, double fluorescence immunohistochemistry also revealed that they preserve their capacity of differentiation into the neural cells in the peri-infarct area. The hBMSC expanded in the FCS-free, PL-containing medium retain their capacity of migration, survival, and differentiation when stereotactically transplanted into the infarct brain. The present findings strongly suggest the clinical utility of PL as a substitute to expand autologous hBMSC for cerebral infarct in the future.
  • Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium-Safety and Efficacy of Clinical Use for Neurotransplantation.
    Shichinohe H; Kuroda S; Sugiyama T; Ito M; Kawabori M; Nishio M; Takeda Y; Koike T; Houkin K
    Translational stroke research, 2, 3, 307, 315, 2011年09月, [査読有り], [国際誌]
    英語, 研究論文(学術雑誌), The donor cell culture in animal serum-free medium is quite important for the clinical application of cell transplantation therapy. This study was aimed to test the hypothesis that the human bone marrow stromal cells (hBMSC) expanded with fetal calf serum (FCS)-free, platelet lysate (PL)-containing medium retain their biological features favoring central nervous system regeneration. The hBMSC were cultured with 5% PL or 10% FCS. Their phenotypes were analyzed with flow cytometry, and their production of growth factors was quantified with enzyme-linked immunosorbent assay. Their capacity of neural differentiation was verified by immunocytochemistry. There was no significant difference in morphology and cell surface marker between the hBMSC-FCS and hBMSC-PL. Both of them were positive for CD44, CD90, CD105, and CD166 and were negative for CD34, CD45, and CD271. The production of human brain-derived neurotrophic factor, human hepatocyte growth factor, human β-nerve growth factor, and human platelet-derived growth factor-BB did not differ between the two groups, although the hBMSC-PL produced significantly more amount of TGF-β1 than the hBMSC-FCS. There was no significant difference in their in vitro differentiation into the neurons and astrocytes between the two groups. The hBMSC expanded with PL-containing medium retain their biological capacity of neural differentiation and neuroprotection. The PL may be a clinically valuable and safe substitute for FCS in expanding the hBMSC for cell therapy.
  • Therapeutic Impact of Human Bone Marrow Stromal Cells Expanded by Animal Serum-Free Medium for Cerebral Infarct in Rats
    Taku Sugiyama; Satoshi Kuroda; Yukari Takeda; Mitsufumi Nishio; Masaki Ito; Hideo Shichinohe; Takao Koike
    NEUROSURGERY, 68, 6, 1733, 1742, 2011年06月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Near-Infrared Fluorescence Labeling Allows Noninvasive Tracking of Bone Marrow Stromal Cells Transplanted Into Rat Infarct Brain
    Taku Sugiyama; Satoshi Kuroda; Toshiya Osanai; Hideo Shichinohe; Yuji Kuge; Masaki Ito; Masahito Kawabori; Yoshinobu Iwasaki
    NEUROSURGERY, 68, 4, 1036, 1047, 2011年04月, [査読有り]
    英語, 研究論文(学術雑誌)
  • 骨髄間質細胞移植は脳梗塞後の局所糖代謝を改善する―小動物用PET/CTによる検討
    宮本倫行; 黒田敏; 七戸秀夫; 伊東雅基; 川堀真人; 趙松吉; 孫田恵一; 久下裕司; 玉木長良; 宝金清博
    脳循環代謝, 23, 1, 142, 142, (一社)日本脳循環代謝学会, 2011年
    英語, 研究論文(その他学術会議資料等)
  • Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, fasudil on axon regeneration in rat spinal cord injury.
    Yasuhiro Chiba; Satoshi Kuroda; Hideo Shichinohe; Masaaki Hokari; Toshiya Osanai; Katsuhiko Maruichi; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki
    Neuropathology : official journal of the Japanese Society of Neuropathology, 30, 3, 241, 50, 3, 2010年06月, [査読有り], [国際誌]
    英語, Transplanted bone marrow stromal cells (BMSC) promote functional recovery after spinal cord injury (SCI) through multiple mechanisms. A Rho kinase inhibitor, Fasudil also enhances axonal regeneration. This study was aimed to evaluate whether combination therapy of BMSC transplantation and Fasudil further enhances axonal regeneration and functional recovery in rats subjected to SCI. Fasudil or vehicle was injected for 2 weeks. BMSC or vehicle transplantation into the rostral site of SCI was performed at 7 days after injury. Neurological symptoms were assessed throughout the experiments. Fluoro-Ruby was injected into the dorsal funiculus of the rostral site of SCI at 63 days after injury. The fate of the transplanted BMSC was examined using immunohistochemistry. BMSC transplantation significantly increased the number of Fluoro-Ruby -labeled fibers of the dorsal corticospinal tracts at the caudal site of SCI, enhancing functional recovery of the hind limbs. Some of the engrafted BMSC were positive for Fluoro-Ruby, neuronal specific nuclear protein and microtubule-associated protein-2, suggesting that they acquired neuronal phenotypes and built synaptic connection with the host's neural circuits. Fasudil treatment also improved axonal continuity, but did not promote functional recovery. Combination therapy dramatically increased the number of Fluoro-Ruby-labeled fibers of the dorsal corticospinal tracts at the caudal site of SCI, but did not further boost the therapeutic effects on locomotor function by BMSC transplantation. The findings suggest that BMSC transplantation and Fasudil provide synergistic effects on axon regeneration after SCI, although further studies would be necessary to further enhance functional recovery.
  • Noninvasive transplantation of bone marrow stromal cells for ischemic stroke: preliminary study with a thermoreversible gelation polymer hydrogel.
    Toshiya Osanai; Satoshi Kuroda; Hiroshi Yasuda; Yasuhiro Chiba; Katsuhiko Maruichi; Masaaki Hokari; Taku Sugiyama; Hideo Shichinohe; Yoshinobu Iwasaki
    Neurosurgery, 66, 6, 1140, 7, 6, 2010年06月, [査読有り], [国際誌]
    英語, OBJECTIVE: Recent studies have indicated that bone marrow stromal cells (BMSCs) have the potential to improve neurological function when transplanted into animal models of cerebral infarct. However, it is still undetermined how the BMSCs should be transplanted to obtain the most efficient therapeutic benefits safely. The aim of this study was to assess whether a thermoreversible gelation polymer (TGP) hydrogel acts as a noninvasive, valuable scaffold in BMSC transplantation for infarct brain. METHODS: The mice were subjected to permanent middle cerebral artery occlusion. Vehicle, BMSC suspension, or the BMSC-TGP construct was transplanted onto the ipsilateral intact neocortex at 7 days after the insult. Neurological symptoms were assessed throughout the experiments. The fate of the transplanted BMSC was examined 8 weeks after transplantation with immunohistochemistry. RESULTS: TGP hydrogel completely disappeared and provoked no inflammation in the host brain. Many transplanted cells were widely engrafted in the ipsilateral cerebrum, including the dorsal neocortex adjacent to the cerebral infarct in the BMSC-TGP construct-treated mice. Their number was significantly larger than in the BMSC-treated mice. The majority were positive for both NeuN and MAP2 and morphologically simulated the neurons. CONCLUSION: The findings suggest that surgical transplantation of tissue-engineered BMSCs onto the intact neocortex enhances the engraftment of donor cells around the cerebral infarct. These data may be useful in developing a noninvasive but efficient paradigm in neural tissue engineering. TGP hydrogel can be a promising candidate for valuable scaffolds in BMSC transplantation for central nervous system disorders because of its unique biochemical properties.
  • 中枢神経再生におけるバイオイメージング
    杉山 拓; 伊東 雅基; 七戸 秀夫; 黒田 敏
    再生医療, 9, 2, 257, 263, (株)メディカルレビュー社, 2010年05月, [査読有り]
    日本語
  • Bone marrow stromal cells and bone marrow-derived mononuclear cells: which are suitable as cell source of transplantation for mice infarct brain?
    Hideo Shichinohe; Satoshi Kuroda; Katsuhiko Maruichi; Toshiya Osanai; Taku Sugiyama; Yasuhiro Chiba; Ayumi Yamaguchi; Yoshinobu Iwasaki
    Neuropathology : official journal of the Japanese Society of Neuropathology, 30, 2, 113, 22, 2, 2010年04月, [査読有り], [国際誌]
    英語, There are few studies that denote whether bone marrow stromal cells (BMSC) and bone marrow-derived mononuclear cells (MNC) show the same therapeutic effects, when directly transplanted into the infarct brain. This study therefore aimed to compare their biological properties and behaviors in the infarct brain. Mouse BMSC were harvested and cultured. Mouse MNC were obtained through centrifugation techniques. Their cell markers were analyzed with FACS analysis. The MNC (10(6) cells; n = 10) or BMSC (2 x 10(5) cells; n = 10) were stereotactically transplanted into the ipsilateral striatum of the mice subjected to permanent middle cerebral artery occlusion at 7 days after the insult. Their survival, migration, and differentiation in the infarct brain were precisely analyzed using immunohistochemistry 4 weeks after transplantation. The MNC were positive for CD34, CD45, CD90, but were negative for Sca-1. The BMSC were positive for CD90 and Sca-1. The transplanted BMSC, but not MNC, extensively migrated into the peri-infarct area. Approximately 20% of the transplanted BMSC expressed a neuronal marker, NeuN in the infarct brain, although only 1.4% of the transplanted MNC expressed NeuN. These findings strongly suggest that there are large, biological differences between MNC and BMSC as cell sources of regenerative medicine for ischemic stroke.
  • Effect of biodegradable fibrin scaffold on survival, migration, and differentiation of transplanted bone marrow stromal cells after cortical injury in rats Laboratory investigation
    Hiroshi Yasuda; Satoshi Kuroda; Hideo Shichinohe; Shintaro Kamei; Ryoichi Kawamura; Yoshinobu Iwasaki
    JOURNAL OF NEUROSURGERY, 112, 2, 336, 344, 2010年02月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Thermoreversible Gelation Polymer (TGP) Hydrogel as a Degradable Scaffold for Bone Marrow Stromal Cell Transplantation
    Toshiya Osanai; Satoshi Kuroda; Hiroshi Yasuda; Yasuhiro Chiba; Katsuhiko Maruichi; Masaaki Hokari; Taku Sugiyama; Hideo Shichinohe; Yoshinobu Iwasaki
    Molecular Imaging for Integrated Medical Therapy and Drug Development, 145, 151, Springer Japan, 2010年
    論文集(書籍)内論文
  • Noninvasive Optical Tracking of Bone Marrow Stromal Cells Transplanted into Rat Cerebral Infarct
    Taku Sugiyama; Satoshi Kuroda; Toshiya Osanai; Katsuhiko Maruichi; Yasuhiro Chiba; Hideo Shichinohe; Yuji Kuge; Nagara Tamaki; Yoshinobu Iwasaki
    Molecular Imaging for Integrated Medical Therapy and Drug Development, 139, 144, Springer Japan, 2010年
    論文集(書籍)内論文
  • Bone Marrow Stromal Cell Transplantation Attenuates Cognitive Dysfunction due to Chronic Cerebral Ischemia in Rats
    Hideo Shichinohe; Satoshi Kuroda; Taku Sugiyama; Masaki Ito; Masahito Kawabori
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 30, 4, 293, 301, 2010年, [査読有り]
    英語, 研究論文(学術雑誌)
  • Transplanted bone marrow stromal cells improves cognitive dysfunction due to diffuse axonal injury in rats
    Katsuhiko Maruichi; Satoshi Kuroda; Yasuhiro Chiba; Masaaki Hokari; Hideo Shichinohe; Kazutoshi Hida; Yoshinobu Iwasaki
    NEUROPATHOLOGY, 29, 4, 422, 432, 2009年08月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: A novel material for CNS tissue engineering
    Hiroyuki Itosaka; Satoshi Kuroda; Hideo Shichinohe; Hiroshi Yasuda; Shunsuke Yano; Shintaro Kamei; Ryoichi Kawamura; Kazutoshi Hida; Yoshinobu Iwasaki
    NEUROPATHOLOGY, 29, 3, 248, 257, 2009年06月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Transplanted bone marrow stromal cells promote axonal regeneration and improve motor function in a rat spinal cord injury model.
    Yasuhiro Chiba; Satoshi Kuroda; Katsuhiko Maruichi; Toshiya Osanai; Masaaki Hokari; Shunsuke Yano; Hideo Shichinohe; Kazutoshi Hida; Yoshinobu Iwasaki
    Neurosurgery, 64, 5, 991, 9, 5, 2009年05月, [査読有り], [国際誌]
    英語, OBJECTIVE: Recent studies have indicated that bone marrow stromal cells (BMSCs) have the potential to improve neurological function when transplanted into animal models of spinal cord injury (SCI). However, it is still unclear how the transplanted BMSCs promote functional recovery after SCI. In this study, therefore, we evaluated how the transplanted BMSCs restore the function of the dorsal corticospinal tracts in the injured spinal cord. METHODS: The rats were subjected to incomplete SCI by means of a pneumatic impact device. BMSC or vehicle transplantation into the rostral site of SCI was performed at 7 days after injury. Neurological symptoms were assessed throughout the experiments. Fluoro-Ruby was injected into the dorsal funiculus of the rostral site of SCI at 63 days after injury. The fate of the transplanted BMSCs was examined using immunohistochemistry. RESULTS: BMSC transplantation significantly enhanced functional recovery of the hind limbs. The number of Fluoro-Ruby-labeled fibers of the dorsal corticospinal tracts at the caudal site of SCI was significantly higher in the BMSC-transplanted animals than in the vehicle-transplanted animals. Some of the engrafted BMSCs were positive for Fluoro-Ruby, NeuN, and MAP2 in the gray matter, suggesting that they acquired neuronal phenotypes and built synaptic connection with the host's neural circuits. Others in the white matter morphologically simulated the astrocytes and were also positive for glial fibrillary acidic protein. CONCLUSION: The findings suggest that the transplanted BMSCs acquire neural cell phenotypes around the injury site and contribute to rebuild the neural circuits, including the corticospinal tract, promoting functional recovery of the hind limbs.
  • Graded model of diffuse axonal injury for studying head injury-induced cognitive dysfunction in rats
    Katsuhiko Maruichi; Satoshi Kuroda; Yasuhiro Chiba; Masaaki Hokari; Hideo Shichinohe; Kazutoshi Hida; Yoshinobu Iwasaki
    NEUROPATHOLOGY, 29, 2, 132, 139, 2009年04月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Edaravone (MCI-186) Scavenges Reactive Oxygen Species and Ameliorates Tissue Damage in the Murine Spinal Cord Injury Model
    Takeshi Aoyama; Kazutoshi Hida; Satoshi Kuroda; Toshitaka Seki; Shunsuke Yano; Hideo Shichinohe; Yoshinobu Iwasaki
    NEUROLOGIA MEDICO-CHIRURGICA, 48, 12, 539, 545, 2008年12月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Bone marrow stromal cells promote neurite extension in organotypic spinal cord slice: Significance for cell transplantation therapy
    Hideo Shichinohe; Satoshi Kuroda; Sachiko Tsuji; Satoshi Yamaguchi; Shunsuke Yano; Jang-Bo Lee; Hiroyuki Kobayashi; Seiji Kikuchi; Kazutoshi Hida; Yoshinobu Iwasaki
    NEUROREHABILITATION AND NEURAL REPAIR, 22, 5, 447, 457, 2008年09月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Mouse model of focal cerebral ischemia using endothelin-1
    Nobutaka Horie; Arme-Lise Maag; Scott A. Hamilton; Hideo Shichinohe; Tonya M. Bliss; Gary K. Steinberg
    JOURNAL OF NEUROSCIENCE METHODS, 173, 2, 286, 290, 2008年08月, [査読有り]
    英語, 研究論文(学術雑誌)
  • An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice
    Tomoko Matoba; Yasuko Orba; Tadaki Suzuki; Yoshinori Makino; Hideo Shichinohe; Satoshi Kuroda; Takahiro Ochiya; Hiroshi Itoh; Shinya Tanaka; Kazuo Nagashima; Hirofumi Sawa
    NEUROPATHOLOGY, 28, 3, 286, 294, 2008年06月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms
    Masaaki Hokari; Satoshi Kuroda; Hideo Shichinohe; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki
    JOURNAL OF NEUROSCIENCE RESEARCH, 86, 5, 1024, 1035, 2008年04月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct
    Hideo Shichinohe; Satoshi Kuroda; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki
    BRAIN RESEARCH, 1183, 138, 147, 2007年12月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Bone marrow stromal cell transplantation preserves gammaaminobutyric acid receptor function in the injured spinal cord
    Shunsuke Yano; Satoshi Kuroda; Hideo Shichinohe; Toshitaka Seki; Takako Ohnishi; Hiroshi Tamagami; Kazutoshi Hida; Yoshinobu Iwasaki
    JOURNAL OF NEUROTRAUMA, 23, 11, 1682, 1692, 2006年11月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species
    Yoshimasa Niiya; Takeo Abumiya; Hideo Shichinohe; Satoshi Kuroda; Seiji Kikuchi; Masahiro Ieko; Sho-ichi Yamagishi; Masayoshi Takeuchi; Takashi Sato; Yoshinobu Iwasaki
    BRAIN RESEARCH, 1108, 179, 187, 2006年09月, [査読有り]
    英語, 研究論文(学術雑誌)
  • The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC) - a preliminary study using microarray analysis
    S Yamaguchi; S Kuroda; H Kobayashi; H Shichinohe; S Yano; K Hida; K Shinpo; S Kikuchi; Y Iwasaki
    BRAIN RESEARCH, 1087, 15, 27, 2006年05月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Improved expression of gamma-aminobutyric acid receptor in mice with cerebral infarct and transplanted bone marrow stromal cells: An autoradiographic and histologic analysis
    Hideo Shichinohe; Satoshi Kuroda; Shunsuke Yano; Takako Ohnishi; Hiroshi Tamagami; Kazutoshi Hida; Yoshinobu Iwasaki
    JOURNAL OF NUCLEAR MEDICINE, 47, 3, 486, 491, 2006年03月, [査読有り]
    英語, 研究論文(学術雑誌)
  • 抗リン脂質抗体症候群に伴う脳主幹動脈閉塞性脳梗塞の6症例
    鐙谷武雄; 七戸秀夫; 中山若樹; 黒田敏; 寺坂俊介; 岩崎喜信
    脳卒中, 28, 1, 194, 2006年03月01日
    日本語
  • Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct? A double labeling study
    S Yano; S Kuroda; H Shichinohe; K Hida; Y Iwasaki
    BRAIN RESEARCH, 1065, 1-2, 60, 67, 2005年12月, [査読有り]
    英語, 研究論文(学術雑誌)
  • In vivo fluorescence tracking of bone marrow stromal cells transplanted into a pneumatic injury model of rat spinal cord
    S Yano; S Kuroda; JB Lee; H Shichinohe; T Seki; J Ikeda; G Nishimura; K Hida; M Tamura; Y Iwasaki
    JOURNAL OF NEUROTRAUMA, 22, 8, 907, 918, 2005年08月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Novel stent/CEA strategy for patients with bilateral carotid artery stenosis and coronary artery disease: Report of 2 cases
    H Shichinohe; S Kuroda; T Asano; S Ushikoshi; T Ishikawa; K Houkin; T Murashita; Y Iwasaki
    NEUROLOGICAL SURGERY, 33, 2, 149, 153, 2005年02月, [査読有り]
    日本語, 研究論文(学術雑誌)
  • 冠動脈病変を合併した両側内頸動脈狭窄症に対するstent/CEA複合治療の経験
    七戸 秀夫; 黒田 敏; 浅野 剛; 牛越 聡; 石川 達哉; 宝金 清博; 村下 十志文; 岩崎 喜信
    Neurological Surgery, 33, 2, 149, 153, (株)医学書院, 2005年02月
    日本語, 症例1:49歳男.構音障害と右不全麻痺で発症し,両側内頸動脈に90%狭窄を認めると共に,慢性心不全,冠動脈三枝疾患の合併が判明した.冠動脈バイパス術(CABG)単独では両側大脳半球の灌流圧が著明に低下する危険が高いと考え,まず無症候性の右内頸動脈起始部の狭窄病変に対してstentを用いた血管形成術を施行した.翌日に左頸動脈内膜剥離術(CEA)および冠動脈バイパス術(CABG)を同時に行った.術後頸動脈の狭窄は改善し,両側性に脳血流量の増加を認め,5年経過し再発はない.症例2:62歳男.2年前,労作性狭心症でstentを併用した血管形成術を施行された.しかし,冠動脈狭窄が再発してCABGの適応となり,術前スクリーニングで両側の頸部内頸動脈に狭窄を指摘された.早期にCABGを実施する必要から,まず狭窄が比較的穏やかな右内頸動脈起始部の狭窄病変に対してSMART stentを留置し,1週間後に左CEAを施行した.その3週間後にCABGを施行し,周術期合併症はなかった
  • Carotid occlusive disease presenting with loss of consciousness
    D Kashiwazaki; S Kuroda; S Terasaka; T Ishikawa; H Shichinohe; T Aoyama; S Ushikoshi; M Nunomura; Y Iwasaki
    NEUROLOGICAL SURGERY, 33, 1, 29, 34, 2005年01月, [査読有り]
    日本語, 研究論文(学術雑誌)
  • Neuroprotective effect of a heat shock protein inducer, geranylgeranylacetone in permanent focal cerebral ischemia
    H Yasuda; H Shichinohe; S Kuroda; T Ishikawa; Y Iwasaki
    BRAIN RESEARCH, 1032, 1-2, 176, 182, 2005年01月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia
    H Shichinohe; S Kuroda; H Yasuda; T Ishikawa; M Iwai; M Horiuchi; Y Iwasaki
    BRAIN RESEARCH, 1029, 2, 200, 206, 2004年12月, [査読有り]
    英語, 研究論文(学術雑誌)
  • A pre-clinical assessment model of rat autogeneic bone marrow stromal cell transplantation into the central nervous system
    JB Lee; S Kuroda; H Shichinohe; S Yano; H Kobayashi; K Hida; Y Iwasaki
    BRAIN RESEARCH PROTOCOLS, 14, 1, 37, 44, 2004年11月, [査読有り]
    英語, 研究論文(学術雑誌)
  • In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging
    H Shichinohe; S Kuroda; JB Lee; G Nishimura; S Yano; T Seki; J Ikeda; M Tamura; Y Iwasaki
    BRAIN RESEARCH PROTOCOLS, 13, 3, 166, 175, 2004年08月, [査読有り]
    英語, 研究論文(学術雑誌)
  • FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release
    H Shichinohe; S Kuroda; T Abumiya; J Ikeda; T Kobayashi; T Yoshimoto; Y Iwasaki
    BRAIN RESEARCH, 1001, 1-2, 51, 59, 2004年03月, [査読有り]
    英語, 研究論文(学術雑誌)
  • 脳ミトコンドリアは虚血においてどのような挙動を示すのか?
    黒田 敏; 七戸 秀夫; 小林 徹; 吉本 哲之; 鐙谷 武雄; 石川 達哉; 多田 光宏; 中井 章人; 宝金 清博; 岩崎 喜信
    Pharma Medica, 22, 2, 130, 130, (株)メディカルレビュー社, 2004年02月
    日本語
  • A case of jugular phlebectasia: Usefulness of color Doppler ultrasonography in the diagnosis
    H Shichinohe; S Kuroda; T Ishikawa; Y Iwasaki
    NEUROLOGICAL SURGERY, 32, 1, 75, 78, 2004年01月, [査読有り]
    日本語, 研究論文(学術雑誌)
  • Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease
    R Nanba; S Kuroda; M Takeda; H Shichinohe; N Nakayama; T Ishikawa; K Houkin; Y Iwasaki
    NEUROLOGICAL SURGERY, 31, 12, 1291, 1295, 2003年12月, [査読有り]
    日本語, 研究論文(学術雑誌)
  • Normalization of cerebral hemodynamics and metabolism after carotid stenting in patients unfit for major surgery
    D Kashiwazaki; S Kuroda; S Ushikoshi; H Shichinohe; T Ishikawa; T Asano; T Shiga; N Tamaki; Y Iwasaki
    NEUROLOGICAL SURGERY, 31, 12, 1315, 1320, 2003年12月, [査読有り]
    日本語, 研究論文(学術雑誌)
  • 成人無症候性もやもや病の臨床像と予後
    難波 理奈; 黒田 敏; 竹田 誠; 七戸 秀夫; 中山 若樹; 石川 達哉; 宝金 清博; 岩崎 喜信
    Neurological Surgery, 31, 12, 1291, 1295, (株)医学書院, 2003年12月
    日本語, 過去10年間に著者らが経験した成人無症候性もやもや病10例(男性4例,女性6例・平均年46.2歳)の臨床像,予後について検討した.脳MRIでは脳梗塞を3例に認め,梗塞部位はMCA-ACAあるいはMCA-PCA境界域,尾状核であった.DSAでは,全例病変は両側に存在し,鈴木の病期分類は30歳代で1〜3期が多く,50歳以降では4〜6期の例が多い傾向にあった.SPECTやPETによる脳循環代謝パラメータでは,内頸動脈領域の脳虚血を4例に認め,うち2例は脳梗塞を有した.平均4.1年間の経過観察中,1例でもやもや病の病期が進行し,脳梗塞を発症したが,その他の9例は経過観察期間中に脳虚血発作を呈した例はなく,うち1例は診断2年目に妊娠し,帝王切開にて無事出産した
  • Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice
    JB Lee; S Kuroda; H Shichinohe; J Ikeda; T Seki; K Hida; M Tada; K Sawada; Y Iwasaki
    NEUROPATHOLOGY, 23, 3, 169, 180, 2003年09月, [査読有り]
    英語, 研究論文(学術雑誌)
  • Three cases of successful stenting for radiation-induced carotid arterial stenosis
    J Kitamura; S Kuroda; S Ushikoshi; K Furukawa; T Asano; H Shichinohe; K Houkin; Y Iwasaki; H Saitoh; K Mitsumori
    NEUROLOGICAL SURGERY, 30, 10, 1097, 1102, 2002年10月, [査読有り]
    日本語, 研究論文(学術雑誌)
  • 放射線照射により生じた頸部頸動脈狭窄に対してステント留置術を行った3症例
    北村 淳; 黒田 敏; 牛越 聡; 古川 浩司; 浅野 剛; 七戸 秀夫; 宝金 清博; 岩崎 喜信; 斉藤 久壽; 三森 研自
    Neurological Surgery, 30, 10, 1097, 1102, (株)医学書院, 2002年10月
    日本語, 舌癌或いは喉頭癌に対して放射線治療の既往があり,頸部内頸動脈狭窄症を認めた3例を対象とし,ステントを併用した血管形成術を施行した.ステントを併用した経皮的血管形成術(PTA)により,全ての病変において十分な狭窄の改善が得られた.狭窄率は,いずれも28%以下と著明に改善した.周術期に脳虚血症状は出現しなかった.経過観察期間中に,DSA又は頸動脈エコーにおいて明らかな再狭窄は認められず,新たな脳梗塞の再発も観察されなかった.合併症は1例で見られ,PTAを行った直後に痙攣が出現したが,その後,消失した
  • もやもや病の脳循環代謝 SPECT/PETによる検討
    七戸 秀夫; 黒田 敏; 宝金 清博; 岩崎 喜信; 志賀 哲; 加藤 千恵次; 玉木 長良
    脳循環代謝, 14, 1, 81, 81, (一社)日本脳循環代謝学会, 2002年03月
    日本語
  • Spinal cord compression due to extramedullary hematopoiesis associated with polycythemia vera - Case report
    Y Ohta; H Shichinohe; K Nagashima
    NEUROLOGIA MEDICO-CHIRURGICA, 42, 1, 40, 43, 2002年01月, [査読有り]
    英語, 研究論文(学術雑誌)
  • 内頸動脈狭窄症に合併した"steal VBI"の2症例
    七戸 秀夫; 黒田 敏; 宝金 清博; 牛越 聡; 岩崎 喜信; 阿部 弘
    Neurological Surgery, 29, 9, 871, 876, (株)医学書院, 2001年09月
    日本語, 視野障害を合併する内頸動脈高度狭窄症に対して,内頸動脈stent留置術を施行し,術前に低下していた後大脳動脈領域の脳血流量が増加し,症状が改善した症例を2例経験した.2例に共通する病態として,脳血管撮影では内頸動脈に高度狭窄が存在し,同側の後交通動脈が太く,これによって内頸動脈領域への側副血行路がよく発達していた.この為,SPECTでは反対側の後大脳動脈の脳血流量やacetazolamide反応性が低下し,その後頭葉に起因する視野狭窄を認めた.症例1(64歳男)では後頭葉に小さな脳梗塞もみられた.頸動脈狭窄症に対してstentを併用した経皮的血管形成術を実施したところ,後頭葉の脳循環が改善すると共に視野障害が軽快した.特に,症状の改善は脳梗塞を有さなかった症例2(64歳男)において顕著であった.いずれの症例においても椎骨動脈の起始部やその遠位部に閉塞性病変は認められなかった
  • Two cases of "steal VPI" with stenosis of the internal carotid artery
    H Shichinohe; S Kuroda; K Houkin; S Ushikoshi; Y Iwasaki; H Abe
    NEUROLOGICAL SURGERY, 29, 9, 871, 876, 2001年09月, [査読有り]
    日本語, 研究論文(学術雑誌)
  • 本態性血小板血症に合併した脳梗塞の2症例
    七戸 秀夫; 黒田 敏; 宝金 清博; 岩崎 慶信; 布村 充
    脳卒中, 23, 1, 136, 136, (一社)日本脳卒中学会, 2001年03月
    日本語
  • 内頸動脈Stent術により,盗血現象による椎骨脳底動脈循環不全"steal VBI"が改善した2症例
    七戸 秀夫; 黒田 敏; 宝金 清博; 阿部 弘; 菊池 陽一; 牛越 聡
    脳卒中, 22, 1, 282, 282, (一社)日本脳卒中学会, 2000年04月
    日本語
  • 頸動脈内膜剥離術と冠動脈バイパス術の一期的手術
    七戸 秀夫; 黒田 敏; 石川 達哉; 宝金 清博; 阿部 弘; 松居 喜郎; 牛越 聡; 菊池 陽一
    新潟医学会雑誌, 113, 11〜12, 575, 575, 新潟医学会, 1999年12月
    日本語
  • 両側頸動脈病変と冠動脈病変を合併した1例
    宝金 清博; 七戸 秀夫; 黒田 敏; 松居 喜朗; 牛越 聡
    治療学, 33, 5, 582, 584, ライフサイエンス出版(株), 1999年05月
    日本語
  • 脳動脈瘤破裂による急性期くも膜下出血のMRI,MRA診断
    青樹 毅; 金子 貞男; 七戸 秀夫; 宝金 清博; 阿部 弘; 三森 研自
    日本脳神経外科学会総会抄録集, 56回, 28, 28, (一社)日本脳神経外科学会, 1997年10月
    日本語
■ その他活動・業績
■ 主な担当授業
  • 医倫理学, 2024年, 博士後期課程, 医学研究科
  • 基本医学総論, 2024年, 修士課程, 医学院
  • 医倫理学序論, 2024年, 修士課程, 医学院
  • 医学総論, 2024年, 博士後期課程, 医学院
  • 医倫理学, 2024年, 博士後期課程, 医学院
  • トランスレーショナルリサーチ概論, 2024年, 学士課程, 医学部
■ 共同研究・競争的資金等の研究課題
  • 脳出血慢性期モデルに対する幹細胞とScaffold合剤の有効性評価
    科学研究費助成事業
    2020年04月01日 - 2023年03月31日
    川堀 真人; 七戸 秀夫
    昨年度製法が確立したラット脳出血モデル(SDラットおよび免疫抑制ラット)に対して出血が吸収された2週後に出血腔内へのセルザイク投与(ラット由来およびヒト由来)を行い、その後1か月間の運動機能改善を評価した。またIn-vitroにおいてセルザイクとBMSCの栄養因子の分泌について評価した。In-vivoでセルザイク投与群の方がBMSC/生理食塩水より神経機能改善効果が有意に高く、脳萎縮率もCellSaic群で低い傾向であった。また、セルザイク投与群での血腫腔周囲の脳由来神経栄養因子(BDNF)量は生理食塩水群よりも有意に多く、BDNF抑制セルザイクは通常のセルザイクよりも神経機能改善の程度が小さかった。OGD環境では、CellSaicの方がBMSCより栄養因子分泌能および細胞増殖能が有意に高かった。
    日本学術振興会, 基盤研究(C), 北海道大学, 20K09382
  • 冷却人工酸素運搬体の経動脈選択的投与による脳保護療法の開発
    科学研究費助成事業
    2016年04月01日 - 2019年03月31日
    鐙谷 武雄; 小松 晃之; 中山 若樹; 数又 研; 七戸 秀夫; 寳金 清博; 長内 俊也
    2時間脳虚血後に10℃に冷却した人工酸素運搬体HemoActを再開通動脈から投与した。この人工酸素運搬体投与+冷却灌流のcombination therapy群を、10℃生理食塩水の同量投与、37℃HemoActの同量投与の二つmonotherapy群と、未治療コントロール群と比較して検討した。その結果、combination therapyの方が梗塞体積を縮小し、脳血流量低下を抑制する傾向にあった。この治療効果は、少なくとも治療7日後まで継続した。また、therapeutic time windowの延長効果の検討では、虚血時間が5時間までは治療効果があることが分かった。
    日本学術振興会, 基盤研究(C), 北海道大学, 16K10708
  • 骨髄間質細胞移植による癒着性くも膜炎及び難治性神経障害性疼痛に対する治療法の確立
    科学研究費助成事業
    2015年04月01日 - 2018年03月31日
    関 俊隆; 笹森 徹; 岩崎 素之; 七戸 秀夫; 寳金 清博
    脊髄癒着性くも膜炎は,くも膜・軟膜に慢性炎症性変化をきたし,慢性進行性に脊髄を障害する.確立された治療法はなく,きわめて治療困難である.難治性疼痛を認めることは稀ではなく,患者の日常生活を著しく損なう.本研究は脊髄損傷後の脊髄癒着性くも膜炎に起因する難治性疼痛の治療法の確立を目的とした.本実験の前に安定した脊髄損傷動物実験モデルを作製することとした.既存の動物脊髄損傷用の脳動脈瘤クリップは高価で継続的な実験が困難であったため,本邦の企業に依頼し動物脊髄損傷用の脳動脈瘤クリップを作製した.既存のクリップと比較して統計学的にも有意差のない脊髄損傷モデルを作製することできた.
    日本学術振興会, 基盤研究(C), 北海道大学, 15K10552
  • iPS細胞を用いた、もやもや病における脳出血発症メカニズムの解析と予防薬の研究
    科学研究費助成事業
    2015年04月01日 - 2018年03月31日
    数又 研; 中山 若樹; 鐙谷 武雄; 七戸 秀夫; 寳金 清博
    iPS細胞より血管内皮細胞を分化誘導した。マイクロアレイを行った結果、もやもや病血管内皮細胞において、tight junction関連遺伝子であるCLDN1, Focal adhesions and hemidesmosomes関連遺伝子であるDST, NEXN, ITGB3が低下していた。RT-PCRでは、ITGB3はもやもや病血管内皮細胞において発現が低下していたが、DST, NEXNは有意な差はなく、CLDN1は明らかなバンドが確認できなかった。血管透過性アッセイにおいてY-27632を添加した際に、健常群では透過性が低下したのに対し、もやもや病においては亢進した。
    日本学術振興会, 基盤研究(C), 北海道大学, 15K10286
  • 重症くも膜下出血の予後は炎症反応制御で改善するか?
    科学研究費助成事業
    2015年04月01日 - 2018年03月31日
    穂刈 正昭; 七戸 秀夫; 中山 若樹; 寳金 清博
    くも膜下出血急性期の炎症反応を制御し、神経損傷を軽減することが本研究の目的である。重症くも膜下出血モデルを作成し、それに対して低体温療法・ミノサイクリン投与を行うことによって、急性期炎症反応の制御および予後改善が可能であるか検討する。本研究を通じてくも膜下出血後の炎症反応に早期低体温療法は運動機能改善を伴う炎症反応の低下を認めたが、minocyclineは炎症反応の低下は認めるものの運動機能回復は認められないという結果であった。
    日本学術振興会, 基盤研究(C), 北海道大学, 15K10284
  • 動脈硬化の治療戦略に役立つ核医学イメージング法:EBMのための実験的研究
    科学研究費助成事業
    2014年04月01日 - 2018年03月31日
    久下 裕司; 東川 桂; 川井 恵一; 浅田 祐士郎; 鐙谷 武雄; 七戸 秀夫; 山下 篤; 玉木 長良; 西嶋 剣一; 志水 陽一
    本研究では、インビトロ、インビボ実験により以下の成果を得た。
    ①インテグリンαvβ3イメージング剤18F-RGD-K5の自動合成法を確立した。②低酸素イメージング剤18F-FMISOが、18F-FDGとは異なり、低酸下のM2マクロファージに集積することを見出した。③18F-FMISOの母体構造である2-nitroimidazole系化合物が動脈硬化病変に集積することを確認した。
    これらの成果は、臨床診断に役立つ動脈硬化イメージング法の構築に資するものである。
    日本学術振興会, 基盤研究(B), 北海道大学, 26293268
  • もやもや病患者由来iPS細胞を用いた血管平滑筋細胞の分化誘導と機能解析
    科学研究費助成事業
    2015年04月01日 - 2017年03月31日
    寳金 清博; 中山 若樹; 数又 研; 鐙谷 武雄; 七戸 秀夫
    もやもや病の病態を解析するため、もやもや病特異的iPS細胞から平滑筋細胞を分化誘導した。まず、iPS細胞から神経堤細胞を分化誘導し、それらの細胞は99%以上でp75陽性であることを確認した。それらの細胞に対して平滑筋細胞へと分化誘導を行ったが、分化誘導の途中で細胞の老化、増殖能力の低下が認められた。最終的に残った細胞に対して免疫染色を行ったところ、ほぼ全ての細胞でα-SMA、SM22陽性であり、平滑筋細胞へと分化していることが示された。しかし、細胞の増殖能力低下のため、解析に必要な十分な細胞数を得ることが困難であった。今後、細胞の老化を防ぐために分化誘導方法を改良する必要があると考えられる。
    日本学術振興会, 挑戦的萌芽研究, 北海道大学, 15K15520
  • 表現促進現象を有する家族性もやもや病のCNV解析
    科学研究費助成事業
    2013年04月01日 - 2016年03月31日
    吉本 哲之; 中山 若樹; 数又 研; 七戸 秀夫; 寳金 清博; 佐々木 秀直; 伊東 雅基
    成人発症もやもや病の親から、小児もやもや病の子が生まれた場合(臨床的表現促進現象)、子はより顕著なもやもや病の遺伝的素因を保有している可能性がある。もやもや病親子例を対象として、全ゲノム網羅的マイクロアレイ遺伝子コピー数多型(CNV)解析を実施した。もやもや病親子15組中、表現促進を認めた10組では、16番染色体短腕上(16p13.3)の410kbpの領域にCNVを認める頻度が高く、遺伝子コピー数が、親世代より子世代で増幅している傾向を認めた。遺伝子コピー数の世代を超えた増幅が臨床的表現促進現象の背景となりうることが示唆され、次世代シーケンス解析による、より詳細な検証が必要である。
    日本学術振興会, 基盤研究(C), 北海道大学, 25462203
  • 脳微小血管内皮細胞の老化、細胞特性におけるSIRT1の病態的役割についての解明
    科学研究費助成事業
    2013年04月01日 - 2015年03月31日
    寳金 清博; 中山 若樹; 数又 研; 鐙谷 武雄; 七戸 秀夫
    本研究では、ウシBMECの過継代による老化モデル実験を行った。過継代P15~20 BMECにおいて巨細胞が出現し、β-galactosidase活性、活性酸素産生が増大していた。次いで、P5 BMECとP15 BMECで細胞の生死、アポトーシス、SIRT1発現を比較した。未刺激では差がなかったが、OGD/再酸素化の負荷刺激をすると、P15 BMECで細胞死、アポトーシスが増加した。一方、SIRT1発現は、P5 BMECでのみ負荷刺激後に増加した。この結果はSIRT1が細胞保護的に働いている可能性を示し、老化細胞でSIRT1の誘導がかかりにくいことが細胞の脆弱性に関連していることを想起させた。
    日本学術振興会, 挑戦的萌芽研究, 北海道大学, 25670612
  • もやもや病における血管内皮前駆細胞の病態解析
    科学研究費助成事業
    2012年04月01日 - 2015年03月31日
    寳金 清博; 黒田 敏; 七戸 秀夫
    1) 患者血中EPCのFACS解析:患者33名、健康対照14名から採血を行った。術前では小児患者、成人患者ともにEPCの有意な細胞数低下が示された。また、術後は有意なCD34+/CD133+細胞の低下がみられた。これら所見は、病変部でのEPC消費亢進を示唆していると考えられた。
    2) もやもや病患者由来iPS細胞の樹立:患者3名、正常対照3名からiPS細胞を作成した。血管内皮細胞への分化誘導を行い検討したところ、患者細胞では管腔形成能の低下がみられた。マイクロアレイとプロテオミクス解析では、患者で発現が低下している遺伝子/タンパク質に血管新生に関与するものが見出され、病因との関連が示唆された。
    日本学術振興会, 基盤研究(B), 北海道大学, 24390336
  • 脳梗塞に対する自己骨髄間質細胞移植治療の研究-標準的な移植治療プロトコールの確立
    科学研究費補助金(基盤研究(B))
    2011年 - 2012年
    七戸 秀夫
    ボランティア由来のBMSC(bone marrow stromal cells)を使用した。血小板濃厚液からPL(platelet lysate)を作成し、基本培地に加えてBMSCを培養した。PLで培養したBMSCは培養速度、栄養因子産生においてFCS(仔ウシ血清)で培養したものとほぼ同等であった。またPLで培養したBMSCは、ラット脳梗塞モデルへの移植後の運動機能回復においてもFCSで培養したものと同等以上であった。また小動物用MRIや18F-FDG PETで、ラット脳梗塞モデルへの移植後の細胞追跡や脳機能回復の画像化を試みた。これらの結果は、次世代の臨床試験プロトコールに取り入れられる。
    文部科学省, 基盤研究(B), 北海道大学, 研究代表者, 競争的資金, 23390342
  • ヒト骨髄幹細胞による神経再生療法の包括的戦略研究
    科学研究費補助金(基盤研究(B))
    2009年 - 2011年
    黒田 敏; 飛騨 一利; 小林 浩之; 七戸 秀夫
    ラット大脳脳挫傷モデルにおいてフィブリンがBMSC移植の際の有用なバイオマテリアルであることを証明した(J Neurosurg誌2010)。新規ポリマーを用いることでマウス脳梗塞モデルへのBMSC移植がより効率的に実施できることを確認した(Neurosurgery誌2010)。骨髄から得られる単核球分画にはBMSCのような脳梗塞に対する再生能力が乏しいことを発見した(Neuropathology誌2010)。慢性脳虚血モデルにおける認知機能の低下をBMSCの脳内移植によって抑制できることを世界で初めて発見した(Dement Geriatr Cogn Disord誌2010)。長波長蛍光物質でBMSCを標識してラット脳梗塞モデルに移植することで頭皮上から移植細胞を可視化した(Neurosurgery誌2011)。ラット脳挫傷モデルにBMSCを頚動脈から移植することで神経症状の改善を認めた(Neurosurgery誌投稿中)。老齢ラットのBMSCをG-CSFとともに培養することでその増殖や移植による治療効果を増強することができることを証明した(Cytokine誌投稿中)。ヒトBMSCを動物蛋白を用いない方法で培養してラット脳梗塞モデルに移植し、その治療効果を証明した(Neurosurgery誌2011)。同様の効果を小動物用MRIにて生体内でも確認した(Cell Transpla...
    文部科学省, 基盤研究(B), 北海道大学, 連携研究者, 競争的資金, 21390400
  • ヒト骨髄間質細胞を用いた中枢神経再生、臨床応用にむけた新たなテクノロジーの研究
    科学研究費補助金(基盤研究(B))
    2008年 - 2010年
    七戸 秀夫; 矢野 俊介; 黒田 敏; 岩崎 喜信; 飛騨 一利; 小林 浩之
    ヒト骨髄間質細胞(BMSC)を利用した中枢神経再生を臨床応用させるため、その効率的な手法の確立と安全性の追求を目指した研究を行い、以下の成果を得た。(1)バイオマトリックスを用いたBMSC培養に成功した。(2)G-CSF(顆粒球コロニー刺激因子)を培養液中に添加すると、BMSCが活性化された。またヒトPL(血小板溶解物)を添加し、動物由来成分を排除した培養を行いその有用性を示した。(3)フィブリンマトリックスやメビオールジェルRはスキャフォールドとして有用であり、病変部へBMSCを効果的にデリバリーすることを示した。(4)移植後のヒトBMSCの挙動を、光イメージング技術やMRIにて非侵襲的、経時的にモニタリングできた。
    文部科学省, 基盤研究(B), 北海道大学, 研究代表者, 競争的資金, 20390377
  • バイオイメージングを用いた移植中枢神経再生の統合的研究
    科学研究費補助金(基盤研究(C))
    2008年 - 2010年
    矢野 俊介; 飛騨 一利; 黒田 敏; 七戸 秀夫; 岩崎 喜信
    この3年間に表記の研究課題に関して数多くの知見を得ることができた。すなわち、自己骨髄から分離した骨髄間質細胞(bone marrow stromal cells;BMSC)の生物学的特性を解明するとともに、MRI、光イメージングなどを多用することで、臨床応用を視野に入れた安全かつ効率的な細胞の培養法、中枢神経への投与法、治療効果判定のための画像診断法を確立するための基礎データを得ることができた。
    文部科学省, 基盤研究(C), 北海道大学, 連携研究者, 競争的資金, 20591701
  • 成人骨髄間質細胞による神経再生メカニズムの包括的治療戦略
    科学研究費補助金(基盤研究(B))
    2005年 - 2007年
    飛騨 一利; 七戸 秀夫; 黒田 敏; 岩崎 喜信; 矢野 俊介; 小林 浩之; 中山 若樹
    蛍光標識した骨髄間質細胞(BMSC)をラット脊髄損傷モデルに移植して、生体において移植されたBMSCを可視化する技術を開発した(J Neurotrauma誌2005)。GFP遺伝子と鉄製剤で標識したBMSCをマウス脳梗塞モデルに移植して、BMSCが脳内で増殖を繰り返していることを証明した(Brain Res誌2005)。ラット脊髄損傷モデル、マウス脳梗塞モデルに移植されたBMSCが神経細胞に分化することで、病変周囲のGABA受容体機能を改善させることをオートラジオグラフィを用いて証明した(J Nucl Med誌2006,J Neurotrauma誌2006)。BMSCの遺伝子プロファイリングを解析してBMSCが神経細胞に分化する能力を有していることを証明した(Brain Res誌2006)。BMSCが有するCXCR4受容体が、脳梗塞周囲で産生されるSDF-1を感知して、脳梗塞周囲に遊走することをノックアウトマウスを用いて証明した(Brain Res誌2007)。BMSCは神経細胞と共存することで神経細胞に分化する能力を有していること、BMSCはさまざまな神経栄養因子を産生することで興奮性アミノ酸に暴露された神経細胞を保護することを、新たに開発した共培養システムを用いて証明した(J Neurosci Res誌2008)。ラット脊髄スライスに移植したBMSCが脊髄の基質を溶解させ...
    文部科学省, 基盤研究(B), 北海道大学, 連携研究者, 競争的資金, 17390389
  • 軸索伸長に力点を置いた骨髄間質細胞を用いた神経再生医療研究
    科学研究費補助金(基盤研究(C))
    2005年 - 2006年
    七戸 秀夫; 小林 浩之; 小林 浩之; 黒田 敏; 飛騨 一利; 矢野 俊介; 岩崎 喜信; 菊地 誠志
    マウス脳梗塞モデル、および、ラット脊髄損傷モデルに骨髄間質細胞(bone marrow stromal cell ; BMSC)を定位的に移植すると、BMSCが病変周囲に遊走して神経細胞特有の表現型を獲得するのみならず、神経細胞にのみ存在する受容体の機能を獲得して、脳梗塞や脊髄損傷周囲における受容体機能を改善させることを明らかとした。これらの結果は、それぞれJ Nucl Med誌(2006)、J Neurotrauma誌(2006)に掲載された。BMSCが神経細胞に分化する際の分子生物学的背景を明らかにする目的で、培養BMSCのマイクロアレイ解析を実施した。その結果、BMSCは神経細胞への分化誘導によって、その遺伝子表現型を変化させることが判明した。この結果はBrain Res誌(2006)に掲載された。BMSCが病変周囲に遊走するためには病変周囲で産生されるSDF-1、および、BMSCの膜表面に存在する3DF-1に特異的受容体であるCXCR4が必須の役割を果たしていることを、CXCR4ノックアウトマウスを用いた実験を実施することで明らかとした。現在、J Cereb Blood Flow Metab誌に投稿中である。BMSCと神経細胞の共培養実験系を確立した。この実験系を活用することにより、BMSCの一部が神経細胞そのものへ分化すること、一部は神経細胞と細胞融合することを初め...
    文部科学省, 基盤研究(C), 北海道大学, 研究代表者, 競争的資金, 17591496
  • 自己骨髄細胞を利用したもやもや病に対する血管新生療法の開発
    科学研究費補助金(萌芽研究)
    2005年 - 2006年
    岩崎 喜信; 七戸 秀夫; 鐙谷 武雄; 石川 達哉; 黒田 敏; 中山 若樹
    マウス脳梗塞モデル、および、ラット脊髄損傷モデルに骨髄間質細胞(bone marrow stromal cell; BMSC)を定位的に移植すると、BMSCが病変周囲に遊走して神経細胞特有の表現型を獲得するのみならず、神経細胞にのみ存在する受容体の機能を獲得して、脳梗塞や脊髄損傷周囲における受容体機能を改善させることを明らかとした。これらの結果は、それぞれJ Nucl Med誌(2006)、J Neurotrauma誌(2006)に掲載された。BMSCが神経細胞に分化する際の分子生物学的背景を明らかにする目的で、培養BMSCのマイクロアレイ解析を実施した。その結果、BMSCは神経細胞への分化誘導によって、その遺伝子表現型を変化させることが判明した。この結果はBrain Res誌(2006)に掲載された。BMSCが病変周囲に遊走するためには病変周囲で産生されるSDF-1、および、BMSCの膜表面に存在するSDF-1に特異的受容体であるCXCR4が必須の役割を果たしていることを、CXCR4ノックアウトマウスを用いた実験を実施することで明らかとした。現在、J Cereb Blood Flow Metab誌に投稿中である。BMSCと神経細胞の共培養実験系を確立した。この実験系を活用することにより、BMSCの一部が神経細胞そのものへ分化すること、一部は神経細胞と細胞融合することを初めて...
    文部科学省, 萌芽研究, 北海道大学, 連携研究者, 競争的資金, 17659437
  • 骨髄幹細胞の細胞融合能を利用した脳腫瘍に対する遺伝子・抗血管新生療法の基礎研究
    科学研究費補助金(基盤研究(B))
    2004年 - 2006年
    石井 伸明; 岩崎 喜信; 岩崎 喜信; 小林 浩之; 黒田 敏; 七戸 秀夫; 矢野 俊介; 吉野 雅美
    ラットおよびマウス骨髄からBMSCを分離培養する実験系を確立した。FACSを用いた解析ではCD34(-)、CD45(+/-)、CD90(+)、Sca1(+)であり、間葉系細胞であることがわかった。Brain Res Protoc誌(2004)に掲載。移植されたBMSCの挙動に関しマウス・ラット脳梗塞・脊髄損傷モデルで検討した。移植細胞は活発な細胞分裂を繰り返し生着することが明らかとなった。Brain Res誌(2005)に掲載。マウスから分離・培養したBMSCの培養液にDMSO, retinoic acid, bFGFを添加して分化誘導を試みた。その結果、BMSCは形態学的には神経細胞に類似したものに変化し、nestinやTuj-1など未分化な神経細胞に特異的なマーカーを発現することが免疫染色により確認された。また、DNAマイクロアレイにより、分化誘導前後におけるBMSCの遺伝子発現プロファイルを検討したところ、BMSCは外的刺激によりその遺伝子発現を変化させ得ること、様々な成長因子を産生することで損傷された中枢神経を保護する役割を有することが示唆された。Brain Res誌(2006)に掲載。細胞移植を促進するためのバイオマテリアルに関して検討したところフィブリンが有用な素材となり得ることが明らかとなった。(投稿準備中)BMSCと神経細胞の融合能および分化能の評価をin v...
    文部科学省, 基盤研究(B), 北海道大学, 連携研究者, 競争的資金, 16390401
  • バイオマテリアル・遺伝子解析を利用した自己骨髄細胞による神経再生治療の研究
    科学研究費補助金(基盤研究(B))
    2003年 - 2005年
    岩崎 喜信; 関 俊隆; 池田 潤; 小林 浩之; 黒田 敏; 七戸 秀夫; 飛騨 一利; 田村 守; 矢野 俊介
    マウスおよびラット大腿骨より骨髄間葉系細胞(BMSC)を分離し、マウス脳梗塞あるいは脊髄損傷モデルに移植する実験系を確立し、Neuropathology誌(2003)、Brain Res Protoc誌(2004)に掲載された。GFPトランスジェニック・マウスからBMSCを採取してマウス脳梗塞あるいはラット脊髄損傷モデルに移植した。移植した細胞が脳や脊髄の中を病変部に向かって遊走する様子を動物が生きたままの状態で観察する実験系を確立した。Brain Res Protoc誌(2004)、J Neurotrauma誌(2005)に掲載された。移植されたBMSCが神経細胞に特異的に存在する受容体を保護するかどうかを、マウス脳梗塞モデル、ラット脊髄損傷モデルを用いてautoradiographyにより解析した。細胞移植が病変周囲における神経受容体を保持する役割を有していることが判明した。J Nucl Med誌(2006)に掲載された。さらにJ Neurotrauma誌に投稿中である。移植されたBMSCが神経回路網を再構築する様子を生体内で観察する目的で、MRIによるマウス脳梗塞モデル、ラット脊髄損傷モデルの画像化システムを確立した。移植されたBMSCが中枢神経内部で活発な細胞分裂を繰り返しながら生着することを明らかとした。Brain Res誌(2005)に掲載された。仔ラット脊髄スラ...
    文部科学省, 基盤研究(B), 北海道大学, 連携研究者, 競争的資金, 15390426
  • 骨髄間葉系幹細胞の移植による脳梗塞・脊髄損傷の治療に関する基礎的研究
    科学研究費補助金(基盤研究(B))
    2002年 - 2005年
    黒田 敏; 飛騨 一利; 田村 守; 澤田 賢一; 池田 潤; 多田 光宏; 矢野 俊介; 関 俊隆; 七戸 秀夫; 岩崎 喜信; 飛騨 一利; 田村 守
    マウスおよびラット大腿骨より骨髄間葉系細胞(BMSC)を分離し、マウス脳梗塞あるいは脊髄損傷モデルに移植する実験系を確立し、Neuropathology誌(2003)、Brain Res Protoc誌(2004)に掲載された。GFPトランスジェニック・マウスからBMSCを採取してマウス脳梗塞あるいはラット脊髄損傷モデルに移植した。移植した細胞が脳や脊髄の中を病変部に向かって遊走する様子を動物が生きたままの状態で観察する実験系を確立した。Brain Res Protoc誌で2004)、J Neurotrauma誌(2005)に掲載された。移植されたBMSCが神経細胞に特異的に存在する受容体を保護するかどうかを、マウス脳梗塞モデル、ラット脊髄損傷モデルを用いてautoradiographyにより解析した。細胞移植が病変周囲における神経受容体を保持する役割を有していることが判明した。J Nucl Med誌(2006)に掲載された。さらにJ Neurotrauma誌に投稿中である。移植されたBMSCが神経回路網を再構築する様子を生体内で観察する目的で、MRIによるマウス脳梗塞モデル、ラット脊髄損傷モデルの画像化システムを確立した。移植されたBMSCが中枢神経内部で活発な細胞分裂を繰り返しながら生着することを明らかとした。Brain Res誌(2005)に掲載された。仔ラット脊髄スラ...
    文部科学省, 基盤研究(B), 北海道大学, 連携研究者, 競争的資金, 14370424